<SEC-DOCUMENT>0001213900-21-001190.txt : 20210108
<SEC-HEADER>0001213900-21-001190.hdr.sgml : 20210108
<ACCEPTANCE-DATETIME>20210108162422
ACCESSION NUMBER:		0001213900-21-001190
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		7
FILED AS OF DATE:		20210108
DATE AS OF CHANGE:		20210108

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CHINA PHARMA HOLDINGS, INC.
		CENTRAL INDEX KEY:			0001106644
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				731564807
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-251973
		FILM NUMBER:		21517723

	BUSINESS ADDRESS:	
		STREET 1:		2ND FLOOR, NO. 17, JINPAN ROAD
		STREET 2:		HAIKOU
		CITY:			HAINAN PROVINCE
		STATE:			F4
		ZIP:			570216
		BUSINESS PHONE:		8689866811730

	MAIL ADDRESS:	
		STREET 1:		2ND FLOOR, NO. 17, JINPAN ROAD
		STREET 2:		HAIKOU
		CITY:			HAINAN PROVINCE
		STATE:			F4
		ZIP:			570216

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TS ELECTRONICS INC
		DATE OF NAME CHANGE:	20030818

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SOFTSTONE INC
		DATE OF NAME CHANGE:	20030128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SOFTSTONE INC /DE/
		DATE OF NAME CHANGE:	20010808
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>ea132953-s3_chinapharma.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">As filed with the Securities and Exchange
Commission on January 8, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Registration No. 333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM S-3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION STATEMENT UNDER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE SECURITIES ACT OF 1933</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>China Pharma Holdings, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 49%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Nevada</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 49%; text-align: center"><FONT STYLE="font-size: 10pt"><B>75-1564807</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>(State or other jurisdiction of<BR>
 incorporation or
    organization)</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>(I.R.S. Employer<BR>
 Identification Number)</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Second Floor, No. 17, Jinpan Road<BR>
Haikou, Hainan Province, China</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>+86- 898-6681-1730 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Address, including zip code, and telephone
number, including area code, of registrant&rsquo;s principal executive offices)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Zhilin Li</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>President and Chief Executive Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2nd Floor, No. 17, Jinpan Road, Haikou,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Hainan Province, China 570216</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>+86- 898-6681-1730 &nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Name, address, including zip code, and
telephone number, including area code, of agent for service)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>With a copy to:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Elizabeth F. Chen, Esq.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pryor Cashman LLP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>7 Times Square</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>New York, New York 10036</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(212) 326-0199</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Approximate date of commencement of
proposed sale to the public</B>: From time to time after this registration statement becomes effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the only securities being registered
on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any of the securities being registered
on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than
securities offered only in connection with dividend or interest reinvestment plans, check the following box. <FONT STYLE="font-family: Wingdings">&thorn;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is filed to register additional
securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities
Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment
filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same offering. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a registration statement
pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission
pursuant to Rule 462(e) under the Securities Act, check the following box. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment
to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes
of securities pursuant to Rule 413(b) under the Securities Act, check the following box. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth
company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller reporting
company&rdquo; and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 30%; text-align: justify"><FONT STYLE="font-size: 10pt">Large accelerated filer</FONT></TD>
    <TD STYLE="width: 2%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="width: 29%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 37%; text-align: justify"><FONT STYLE="font-size: 10pt">Accelerated filer</FONT></TD>
    <TD STYLE="width: 2%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Non-accelerated filer</FONT></TD>
    <TD STYLE="text-align: justify">&#9746;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Smaller reporting company</FONT></TD>
    <TD STYLE="text-align: justify">&#9746;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Emerging growth company</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 7(a)(2)(B) of Securities Act. <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CALCULATION OF REGISTRATION FEE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Title of each Class of Security being Registered</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Amount being</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Registered</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(1)</B></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Proposed Maximum</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Offering Price Per</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Security<BR>
 (2) </B></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Proposed Maximum</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Aggregate Offering</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Price<BR>
 (2)</B></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Amount of</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Registration Fee<BR>
 (3)</B></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%">Common Stock, $0.001 par value per share</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Preferred Stock, $0.001 par value per share</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Debt Securities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Warrants</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Rights</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">Units</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">50,000,000</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">N/A&nbsp;</P></TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">50,000,000</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">5,455.00</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">There are being registered under this Registration Statement
such indeterminate number of shares of common stock and preferred stock, such indeterminate principal amount of debt securities,
such indeterminate number of warrants to purchase common stock, preferred stock and/or debt securities, such indeterminate number
of rights to purchase common stock or preferred stock and such indeterminate number of units as may be sold by the Registrant
from time to time, which together shall have an aggregate initial offering price not to exceed $50,000,000. If the Registrant
issues any debt securities at an original issue discount, then the offering price of such debt securities shall be in such greater
principal amount at maturity as shall result in an aggregate offering price not to exceed $50,000,000, less the aggregate dollar
amount of all securities previously issued hereunder. The Registrant may sell any securities it is registering under this Registration
Statement separately or as units with the other securities it is registering under this Registration Statement. The Registrant
will determine, from time to time, the proposed maximum offering price per unit in connection with its issuance of the securities
it is registering under this Registration Statement. The securities it is registering under this Registration Statement also include
such indeterminate number of shares of common stock and preferred stock and such indeterminate principal amount of debt securities
as the Registrant may issue upon conversion of or exchange for preferred stock or debt securities that provide for conversion
or exchange, upon exercise of warrants or rights or pursuant to the anti-dilution provisions of any of such securities. In addition,
pursuant to Rule 416 under the Securities Act of 1933 (the &ldquo;Securities Act&rdquo;), the shares the Registrant is registering
under this Registration Statement include such indeterminate number of shares of common stock and preferred stock as may be issuable
with respect to the shares the Registrant is registering as a result of stock splits, stock dividends or similar transactions.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify">The Registrant will determine the proposed maximum aggregate
offering price per class of security from time to time in connection with its issuance of the securities the Registrant is registering
under this Registration Statement and the Registrant is not specifying such price as to each class of security pursuant to General
Instruction II.D. of Form S-3 under the Securities Act.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">(3)</TD><TD STYLE="text-align: justify">Calculated pursuant to Rule 457(o) under the Securities
Act, which permits the registration fee to be calculated on the basis of the maximum aggregate offering price of all securities
listed.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Registrant hereby amends this registration
statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment
which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of
the Securities Act of 1933 or until the registration statement shall become effective on such date as the Commission, acting pursuant
to said section 8(a), may determine.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Red"><B>THE INFORMATION
IN THIS PROSPECTUS IS NOT COMPLETE AND MAY BE CHANGED. WE MAY NOT SELL THESE SECURITIES PUBLICLY UNTIL THE REGISTRATION STATEMENT
FILED WITH THE SECURITIES AND EXCHANGE COMMISSION IS EFFECTIVE. THIS PROSPECTUS IS NOT AN OFFER TO SELL THESE SECURITIES AND IT
IS NOT SOLICITING AN OFFER TO BUY THESE SECURITIES IN ANY STATE WHERE THE OFFER OR SALE IS NOT PERMITTED.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Subject to Completion, Dated January 8,
2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Prospectus</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CHINA PHARMA HOLDINGS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">$50,000,000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Common Stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Preferred Stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Debt Securities</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Warrants</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Rights</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Units</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may offer and sell, from time to time in one or more offerings,
any combination of common stock, preferred stock, debt securities (which may be convertible into or exchangeable for common stock),
warrants, rights or units that include any of these securities having an aggregate initial offering price not exceeding $50,000,000.
When we decide to sell a particular class or series of securities, we will provide specific terms of the offered securities in
a prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will provide specific terms of the offerings
of our securities in supplements to this prospectus. The prospectus supplement may also add, update or change information contained
in or incorporated by reference into this prospectus. You should read this prospectus and any prospectus supplement, as well as
the documents incorporated by reference or deemed to be incorporated by reference into this prospectus, carefully before you invest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus may not be used to offer
or sell our securities unless accompanied by a prospectus supplement relating to the offered securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our common stock is traded on the NYSE American (formerly known
as AMEX) under the symbol &ldquo;CPHI&rdquo;. The closing price for our common stock on NYSE American on January 7, 2021 was $0.55
per share. Each prospectus supplement will contain information, where applicable, as to any listing on the NYSE American or any
other securities exchange of the securities covered by the prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These securities may be sold directly by
us, through dealers or agents designated from time to time, to or through underwriters or through a combination of these methods.
See &ldquo;Plan of Distribution&rdquo; in this prospectus. We may also describe the plan of distribution for any particular offering
of our securities in a prospectus supplement. If any agents, underwriters or dealers are involved in the sale of any securities
in respect of which this prospectus is being delivered, we will disclose their names and the nature of our arrangements with them
in a prospectus supplement. The net proceeds we expect to receive from any such sale will also be included in a prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Investing in our securities
involves risk. You should carefully consider the risk factors beginning on page 5 of this prospectus before investing in our
securities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NEITHER THE SECURITIES AND EXCHANGE
COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES, OR PASSED UPON THE ADEQUACY OR
ACCURACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">The date of
this prospectus is</FONT> __________<FONT STYLE="font-size: 10pt">, 2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Table of Contents</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; width: 95%"><A HREF="#a_001"><FONT STYLE="font-size: 10pt">ABOUT THIS PROSPECTUS</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: middle; width: 5%">1</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top"><A HREF="#a_002"><FONT STYLE="font-size: 10pt">ABOUT OUR COMPANY</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: middle">2</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><A HREF="#a_003"><FONT STYLE="font-size: 10pt">NOTE REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: middle">4</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top"><A HREF="#a_004"><FONT STYLE="font-size: 10pt">RISK FACTORS</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: middle">5</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><A HREF="#a_005"><FONT STYLE="font-size: 10pt">USE OF PROCEEDS</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: middle">6</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top"><A HREF="#a_006"><FONT STYLE="font-size: 10pt">THE SECURITIES WE MAY OFFER</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: middle">6</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><A HREF="#a_007"><FONT STYLE="font-size: 10pt">DESCRIPTION OF COMMON STOCK</FONT></A></TD>
    <TD STYLE="vertical-align: middle; text-align: center">6</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top"><A HREF="#a_008"><FONT STYLE="font-size: 10pt">DESCRIPTION OF PREFERRED STOCK</FONT></A></TD>
    <TD STYLE="vertical-align: middle; text-align: center">7</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><A HREF="#a_009"><FONT STYLE="font-size: 10pt">DESCRIPTION OF DEBT SECURITIES</FONT></A></TD>
    <TD STYLE="vertical-align: middle; text-align: center">8</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top"><A HREF="#a_010"><FONT STYLE="font-size: 10pt">DESCRIPTION OF WARRANTS</FONT></A></TD>
    <TD STYLE="vertical-align: middle; text-align: center">9</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><A HREF="#a_011"><FONT STYLE="font-size: 10pt">DESCRIPTION OF RIGHTS</FONT></A></TD>
    <TD STYLE="vertical-align: middle; text-align: center">11</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top"><A HREF="#a_012"><FONT STYLE="font-size: 10pt">DESCRIPTION OF UNITS</FONT></A></TD>
    <TD STYLE="vertical-align: middle; text-align: center">12</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><A HREF="#a_013"><FONT STYLE="font-size: 10pt">PLAN OF DISTRIBUTION</FONT></A></TD>
    <TD STYLE="vertical-align: middle; text-align: center">13</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top"><A HREF="#a_014"><FONT STYLE="font-size: 10pt">LEGAL MATTERS</FONT></A></TD>
    <TD STYLE="vertical-align: middle; text-align: center">15</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><A HREF="#a_015"><FONT STYLE="font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="vertical-align: middle; text-align: center">15</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top"><A HREF="#a_016"><FONT STYLE="font-size: 10pt">WHERE YOU CAN FIND MORE INFORMATION</FONT></A></TD>
    <TD STYLE="vertical-align: middle; text-align: center">15</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><A HREF="#a_017"><FONT STYLE="font-size: 10pt">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</FONT></A></TD>
    <TD STYLE="vertical-align: middle; text-align: center">15</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>You should rely only on the information
contained or incorporated by reference in this prospectus or any prospectus supplement. We have not authorized anyone to provide
you with information different from that contained or incorporated by reference into this prospectus. If any person does provide
you with information that differs from what is contained or incorporated by reference in this prospectus, you should not rely on
it. No dealer, salesperson or other person is authorized to give any information or to represent anything not contained in this
prospectus. You should assume that the information contained in this prospectus or any prospectus supplement is accurate only as
of the date on the front of the document and that any information contained in any document we have incorporated by reference is
accurate only as of the date of the document incorporated by reference, regardless of the time of delivery of this prospectus or
any prospectus supplement or any sale of a security. These documents are not an offer to sell or a solicitation of an offer to
buy these securities in any circumstances under which the offer or solicitation is unlawful.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 6pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_001"></A>ABOUT THIS PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This prospectus is part
of a Registration Statement on Form S-3 that we filed with the Securities and Exchange Commission utilizing a &ldquo;shelf&rdquo;
registration process. Under this shelf process, we may sell common stock, preferred stock, debt securities (which may be convertible
into or exchangeable for common stock), warrants, rights or units from time to time in one or more offerings at indeterminate prices,
up to an aggregate maximum offering price for all such securities of $50,000,000. This prospectus provides you with a general description
of the securities we may offer. Each time we sell any securities under this prospectus, we will provide a prospectus supplement
that will contain specific information about the terms of that offering. The prospectus supplement may also add, update or change
information contained in this prospectus. You should read both this prospectus and any prospectus supplement together with additional
information described below under the heading &ldquo;Where You Can Find More Information.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus and
any accompanying prospectus supplement or other offering materials do not contain all of the information included in the registration
statement as permitted by the rules and regulations of the SEC. For further information, we refer you to the registration statement
on Form S-3, including its exhibits. We are subject to the informational requirements of the Securities Exchange Act of 1934, as
amended (the &ldquo;Exchange Act&rdquo;), and, therefore, file reports and other information with the SEC. Statements contained
in this prospectus and any accompanying prospectus supplement, or other offering materials about the provisions or contents of
any agreement or other document are only summaries. If SEC rules require that any agreement or document be filed as an exhibit
to the registration statement, you should refer to that agreement or document for its complete contents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You should not assume
that the information in this prospectus, any prospectus supplement or any other offering materials is accurate as of any date other
than the date on the front of each document. Our business, financial condition, results of operations and prospects may have changed
since then.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise indicated
in this prospectus or the context otherwise requires, references to &ldquo;we&rdquo;, &ldquo;us&rdquo;, &ldquo;China Pharma&rdquo;,
&ldquo;the Company&rdquo; or &ldquo;our Company&rdquo; refer to China Pharma Holdings, Inc. and its wholly owned subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

</DIV>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 6pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_002"></A>ABOUT OUR COMPANY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Organization and Nature of Operations </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">China Pharma Holdings,
Inc., a Nevada corporation, owns 100% of Onny Investment Limited (Onny), a British Virgin Islands corporation, which owns 100%
of Hainan Helpson Medical &amp; Biotechnology Co., Ltd (Helpson), a company organized under the laws of the People&rsquo;s Republic
of China (the &ldquo;PRC&rdquo;). China Pharma Holdings, Inc. and its subsidiaries are referred to herein as the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Onny acquired 100%
of the ownership in Helpson on May 25, 2005, by entering into an Equity Transfer Agreement with Helpson&rsquo;s three former shareholders.
The transaction was approved by the Commercial Bureau of Hainan Province on June 12, 2005 and Helpson received the Certificate
of Approval for Establishment of Enterprises with Foreign Investment in the PRC on the same day. Helpson received its business
license evidencing its WFOE (Wholly Foreign Owned Enterprise) status on June 21, 2005.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our corporate organizational
chart is set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><IMG SRC="image_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has acquired
and continues to acquire well-accepted medical formulas to add to its diverse portfolio of Western and Chinese medicines.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Business Overview &amp; Recent Developments</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are principally
engaged in the development, manufacture and marketing of pharmaceutical products for human use in connection with a variety of
high-incidence and high-mortality diseases and medical conditions prevalent in the PRC. All of our operations are conducted in
the PRC, where our manufacturing facilities are located. We manufacture pharmaceutical products in the form of dry powder injectables,
liquid injectables, tablets, capsules, and cephalosporin oral solutions. The majority of our pharmaceutical products are sold on
a prescription basis and all have been approved for at least one or more therapeutic indications by the National Medical Products
Administration (the &ldquo;NMPA&rdquo;, formerly China Food and Drug Administration, CFDA) based upon demonstrated safety and efficacy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">China&rsquo;s consistency
evaluation of generic drugs had continued to proceed in 2019. The supporting policies from central and provincial governments have
been constantly issued. We have always taken the tasks of facilitating the consistency evaluation as our top priority, and worked
on them actively. However, due to the continuous dynamic changes of the detailed policies, future market, expected investment,
and return of investment (&ldquo;ROI&rdquo;) for each drug&rsquo;s consistency evaluation, the whole industry, including us, has
been making slow progresses in terms of the consistency evaluation.</P>

</div>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 6pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have to take a more
cautious and flexible attitude towards the initiating and progressing any project for an existing product&rsquo;s consistency evaluation
and to cope with the changing macro environment of drug sales in China. On one hand, since initiated in 2018, two rounds of &ldquo;4
+ 7&rdquo; (refers to 11 selected pilot cities, including 4 municipalities and 7 other cities) Group Purchasing Organization (&ldquo;GPO&rdquo;)
activities had been carried out by the end of 2019, which significantly reduced the price of the drugs that won the bids. On the
other hand, the consistency evaluation has been adopted as one of the qualification standards for participating in the GPO activities.
As a result, we need balance at least the two factors above before making decisions for any project.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we continue
to explore in the field of comprehensive healthcare. Comprehensive healthcare is a general concept proposed according to the development
of the times, social needs and changes in disease spectrum. It focuses on people&rsquo;s daily life, aging and disease, pays attention
to all kinds of risk factors and misunderstandings affecting health, and calls for self-health management, and advocates the comprehensive
care of the entire process of life. It covers all kinds of health-related information, products and services, as well as actions
taken by various organizations to meet the health needs. We launched Noni enzyme, a natural, healthy and nutrition-rich food supplement
at the end of 2018, and wash-free sanitizer and mask in early 2020 to address the market needs caused by COVID-19 in China.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will continue to
optimize our product structure and actively respond to the current health needs of human beings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Market Trends</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As the medical reform
deepens, the GPO program has been expanded from pilot cities to the whole country, which pressed hospitals to control drug prices
to reduce overall costs. The pressure of price reduction has been further transmitted to pharmaceutical manufacturers. We believe
that the price control is still one of the key themes in the pharmaceutical industry in the future; and pharmaceutical manufacturing
companies&rsquo; revenues are under obvious pressure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Novel coronavirus pneumonia
(COVID-19) refers to the pneumonia caused by the 2019 novel coronavirus infection. World Health Organization (WHO) convened the
COVID-19 Emergency Committee for the fifth time to assess the global outbreak situation and provide recommendations for response
on October 29, 2020. WHO then announced that the outbreak of COVID-19 continues to constitute a &ldquo;public health emergency
of international concern&rdquo; on October 30, 2020. Due to the impact of COVID-19 pandemic, there has been a phenomenon that people
are afraid of going to the hospital. The decline in the number of hospital outpatients has created a negative pressure on sales
for pharmaceutical companies, including ours.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a generic drug company
we are presented with a huge domestic market. We believe that through further upgrades and consistency evaluations, we will be
able to meet the European and American production standards, which enables us to export our products to overseas markets. In the
future, cost management and control ability will gradually become an important factor in determining the competitiveness of generic
pharmaceutical enterprises. Although price control leads to a decline in the profitability, the GPO&rsquo;s winning enterprise
has a good chance of achieving price-for-volume in order to increase its market share and support its continuous innovation transformation.
In addition, consumption upgrading in China drives the increase of optional consumption. With the improvement of residents&rsquo;
quality of life, the healthcare demand is also changing. We believe that there are a large number of unmet demands in comprehensive
healthcare and Internet healthcare sectors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In general, demand
for pharmaceutical products is still experiencing steady growth in China. We believe the ongoing generic drug consistency evaluations
and reform of China&rsquo;s drug production registration and review policies will have major effects on the future development
of our industry and may change its business patterns. We will continue to actively adapt to the national policy guidance and further
evaluate market conditions for our existing products, and competition in the market in order to optimize our development strategy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Executive Offices</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our principal executive
offices are located at 2nd Floor, No. 17, Jinpan Road, Haikou, Hainan Province, China. Our telephone number at that address is
+86-898-66811730.</P>

</div>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 6pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_003"></A>NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The statements contained
in this Form S-3 that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities
Act, and Section 21E of the Exchange Act. These include statements about the Company&rsquo;s expectations, beliefs, intentions
or strategies for the future, which are indicated by words or phrases such as &ldquo;anticipate&rdquo;, &ldquo;expect&rdquo;, &ldquo;intend&rdquo;,
&ldquo;plan&rdquo;, &ldquo;will&rdquo;, &ldquo;the Company believes&rdquo;, &ldquo;management believes&rdquo; and similar words
or phrases. The forward-looking statements are based on the Company&rsquo;s current expectations and are subject to certain risks,
uncertainties and assumptions. The Company&rsquo;s actual results could differ materially from results anticipated in these forward-looking
statements. All forward-looking statements included in this document are based on information available to the Company on the date
hereof, and the Company assumes no obligation to update any such forward-looking statements.</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_004"></A>RISK FACTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Investing in our common
stock involves risk. You should carefully consider the specific risks discussed or incorporated by reference into the applicable
prospectus supplement, together with all the other information contained in the prospectus supplement or incorporated by reference
into this prospectus and the applicable prospectus supplement. You should also consider the risks, uncertainties and assumptions
discussed under the caption &ldquo;Risk Factors&rdquo; included in our Annual Report on Form 10-K for the year ended December 31,
2019, and in subsequent filings, which are incorporated by reference into this prospectus. These risk factors may be amended, supplemented
or superseded from time to time by other reports we file with the SEC in the future or by a prospectus supplement relating to a
particular offering of common stock. These risks and uncertainties are not the only risks and uncertainties we face. Additional
risks and uncertainties not presently known to us, or that we currently view as immaterial, may also impair our business. If any
of the risks or uncertainties described in our SEC filings or any prospectus supplement or any additional risks and uncertainties
actually occur, our business, financial condition and results of operations could be materially and adversely affected. In that
case, the trading price of our securities could decline and you might lose all or part of your investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks Related to Our Securities and the Offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Future sales
or other dilution of our equity could depress the market price of our common stock.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Sales of our common
stock, preferred stock, warrants, rights or convertible debt securities, or any combination of the foregoing, in the public market,
or the perception that such sales could occur, could negatively impact the price of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the issuance
of additional shares of our common stock, securities convertible into or exercisable for our common stock, other equity-linked
securities, including preferred stock, warrants or rights or any combination of these securities pursuant to this prospectus will
dilute the ownership interest of our common shareholders and could depress the market price of our common stock and impair our
ability to raise capital through the sale of additional equity securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may need to seek
additional capital. If this additional financing is obtained through the issuance of equity securities, debt securities convertible
into equity or options, warrants or rights to acquire equity securities, our existing shareholders could experience significant
dilution upon the issuance, conversion or exercise of such securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Our management
will have broad discretion over the use of the proceeds we receive from the sale our securities pursuant to this prospectus and
might not apply the proceeds in ways that increase the value of your investment.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our management will
have broad discretion to use the net proceeds from any offerings under this prospectus, and you will be relying on the judgment
of our management regarding the application of these proceeds. Except as described in any prospectus supplement or in any related
free writing prospectus that we may authorize to be provided to you, the net proceeds received by us from our sale of the securities
described in this prospectus will be added to our general funds and will be used for general corporate purposes. Our management
might not apply the net proceeds from offerings of our securities in ways that increase the value of your investment and might
not be able to yield a significant return, if any, on any investment of such net proceeds. You may not have the opportunity to
influence our decisions on how to use such proceeds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_005"></A>USE OF PROCEEDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as otherwise
provided in the applicable prospectus supplement, we intend to use the net proceeds from the sale of the securities covered by
this prospectus for general corporate purposes, which may include working capital, capital expenditures, research and development
expenditures, acquisitions of new technologies or businesses and investments. Additional information on the use of net proceeds
from an offering of securities covered by this prospectus may be set forth in the prospectus supplement relating to the specific
offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_006"></A>THE SECURITIES WE MAY OFFER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The descriptions of
the securities contained in this prospectus, together with any applicable prospectus supplement, summarize all the material terms
and provisions of the various types of securities that we may offer. We will describe in the applicable prospectus supplement relating
to a particular offering the specific terms of the securities offered by that prospectus supplement. If we indicate in the applicable
prospectus supplement, the terms of the securities may differ from the terms we have summarized below. We will also include in
the prospectus supplement information, where applicable, about material United States federal income tax considerations relating
to the securities, and the securities exchange, if any, on which the securities will be listed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We may sell from time to
time, in one or more offerings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">shares of our common stock,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">shares of our preferred stock,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">debt securities (which may be convertible into or exchangeable for common stock),</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">warrants to purchase our common stock;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">rights to purchase our common stock and/or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">units consisting of the forgoing.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This prospectus may not
be used to consummate a sale of securities unless it is accompanied by a prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_007"></A>DESCRIPTION OF CAPITAL STOCK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following description
of our capital stock together with the additional information we include in any applicable prospectus supplement, summarizes the
material terms and provisions of the capital stock that we may offer under this prospectus but is not complete. For the complete
terms of our capital stock, please refer to our articles of incorporation and our bylaws, as amended from time to time. While the
terms we have summarized below will apply generally to any future capital stock that we may offer, we will describe the specific
terms of any series of these securities in more detail in the applicable prospectus supplement. If we so indicate in a prospectus
supplement, the terms of any capital stock we offer under that prospectus supplement may differ from the terms we describe below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our authorized capital stock consists of ninety-five million
(95,000,000) shares of common stock, $0.001 par value per share and five million (5,000,000) shares of preferred stock, $0.001
par value per share. The authorized and unissued shares of capital stock are available for issuance without further action by our
shareholders, unless such action is required by applicable law or the rules of any stock exchange on which our securities may be
listed. Unless approval of our shareholders is so required, our board of directors will not seek shareholder approval for the issuance
and sale of our capital stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of January 8, 2021, there were 45,579,557 shares of our common
stock outstanding. The holders of our common stock are entitled to such dividends as our board of directors may declare from legally
available funds. The holders of our common stock are entitled to one vote per share on any matter to be voted upon by shareholders.
Our articles of incorporation or our bylaws, as amended from time to time, do not provide for cumulative voting. No holder of our
common stock has any preemptive right to subscribe for any shares of capital stock issued in the future under the Nevada Revised
Statutes, our articles of incorporation or our bylaws, as amended from time to time. Our common stock has no preemptive or conversion
rights or other subscription rights. There are no redemption or sinking fund provisions applicable to the common stock.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All shares of common
stock offered hereby will, when issued, be fully paid and non-assessable, including shares of common stock issued upon exercise
of common stock warrants or common stock purchase rights, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our common stock is quoted on the NYSE American
under the symbol &ldquo;CPHI&rdquo;. The transfer agent and registrar for our common stock is Equiniti Trust Company (f/k/a Corporate
Stock Transfer), 3200 E Cherry Creek South Dr Ste 430, Denver, CO 80209.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B><A NAME="a_008"></A>Preferred Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of January 8, 2021,
no shares of preferred stock had been issued or were outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board of directors has the authority to issue up to 5,000,000
shares of preferred stock in one or more series and to determine the rights and preferences of the shares of any such series without
stockholder approval. Our board of directors has the authority to fix the designation and powers, rights and preferences and the
qualifications, limitations or restrictions with respect to each class or series of such class without further vote or action by
the stockholders, unless action is required by applicable law or the rules of any stock exchange on which our securities may be
listed. The ability of our board of directors to issue preferred stock without stockholder approval could have the effect of delaying,
deferring or preventing a change of control of us or the removal of existing management. Further, our board of directors may authorize
the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of
the holders of our common stock. Additionally, the issuance of preferred stock may have the effect of decreasing the market price
of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will file as an
exhibit to the registration statement of which this prospectus is a part, or will incorporate by reference from reports that we
file with the SEC, the form of any certificate of designation that describes the terms of the series of preferred stock we are
offering before the issuance of that series of preferred stock. This description will include, but not be limited to, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the title and stated value;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the number of shares we are offering;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the liquidation preference per share;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the purchase price;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the dividend rate, period and payment date and method of calculation for dividends;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">whether dividends will be cumulative or non-cumulative and, if cumulative, the date from which
dividends will accumulate;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the provisions for a sinking fund, if any;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the provisions for redemption or repurchase, if applicable, and any restrictions on our ability
to exercise those redemption and repurchase rights;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">whether the preferred stock will be convertible into our common stock, and, if applicable, the
conversion price, or how it will be calculated, and the conversion period;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">whether the preferred stock will be exchangeable into debt securities, and, if applicable, the
exchange price, or how it will be calculated, and the exchange period;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">voting rights, if any, of the preferred stock;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">preemptive rights, if any;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">restrictions on transfer, sale or other assignment, if any;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">a discussion of any material United States federal income tax considerations applicable to the
preferred stock;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the relative ranking and preferences of the preferred stock as to dividend rights and rights if
we liquidate, dissolve or wind up our affairs;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any limitations on the issuance of any class or series of preferred stock ranking senior to or
on a parity with the series of preferred stock as to dividend rights and rights if we liquidate, dissolve or wind up our affairs;
and</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any other specific terms, preferences, rights or limitations of, or restrictions on, the preferred
stock.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_009"></A>DESCRIPTION OF DEBT SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue debt securities,
in one or more series, as either senior or subordinated debt or as senior or subordinated convertible debt. When we offer to sell
debt securities, we will describe the specific terms of any debt securities offered from time to time in a supplement to this prospectus,
which may supplement or change the terms outlined below. Senior debt securities will be issued under one or more senior indentures,
dated as of a date prior to such issuance, between us and a trustee to be named in a prospectus supplement, as amended or supplemented
from time to time. Any subordinated debt securities will be issued under one or more subordinated indentures, dated as of a date
prior to such issuance, between us and a trustee to be named in a prospectus supplement, as amended or supplemented from time to
time. The indentures will be subject to and governed by the Trust Indenture Act of 1939, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Before we issue any
debt securities, the form of indentures will be filed with the SEC and incorporated by reference as an exhibit to the registration
statement of which this prospectus is a part or as an exhibit to a current report on Form 8-K. For the complete terms of the debt
securities, you should refer to the applicable prospectus supplement and the form of indentures for those particular debt securities.
We encourage you to read the applicable prospectus supplement and the form of indenture for those particular debt securities before
you purchase any of our debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will describe in
the applicable prospectus supplement the terms of the series of debt securities being offered, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the title;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">whether or not such debt securities are guaranteed;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the principal amount being offered, and if a series, the total amount authorized and the total
amount outstanding;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any limit on the amount that may be issued;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">whether or not we will issue the series of debt securities in global form, the terms and who the
depositary will be;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the maturity date;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the annual interest rate, which may be fixed or variable, or the method for determining the rate
and the date interest will begin to accrue, the dates interest will be payable and the regular record dates for interest payment
dates or the method for determining such dates;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">whether or not the debt securities will be secured or unsecured, and the terms of any secured debt;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the terms of the subordination of any series of subordinated debt;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the place where payments will be payable;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">restrictions on transfer, sale or other assignment, if any;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">our right, if any, to defer payment of interest and the maximum length of any such deferral period;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the date, if any, after which, and the price at which, we may, at our option, redeem the series
of debt securities pursuant to any optional or provisional redemption provisions and the terms of those redemption provisions;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the date, if any, on which, and the price at which we are obligated, pursuant to any mandatory
sinking fund or analogous fund provisions or otherwise, to redeem, or at the holder&rsquo;s option to purchase, the series of debt
securities and the currency or currency unit in which the debt securities are payable;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any restrictions our ability and/or the ability of our subsidiaries to:</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify; padding-right: 0.5in">incur additional indebtedness;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify; padding-right: 0.5in">issue additional securities;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify; padding-right: 0.5in">create liens;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify; padding-right: 0.5in">pay dividends and make distributions in respect of our capital stock and
the capital stock of our subsidiaries;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify; padding-right: 0.5in">redeem capital stock;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify; padding-right: 0.5in">place restrictions on our subsidiaries&rsquo; ability to pay dividends, make
distributions or transfer assets;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify; padding-right: 0.5in">make investments or other restricted payments;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify; padding-right: 0.5in">sell or otherwise dispose of assets;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify; padding-right: 0.5in">enter into sale-leaseback transactions;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify; padding-right: 0.5in">engage in transactions with stockholders and affiliates;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify; padding-right: 0.5in">issue or sell stock of our subsidiaries; or</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify; padding-right: 0.5in">effect a consolidation or merger;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">whether the indenture will require us to maintain any interest coverage, fixed charge, cash flow-based,
asset-based or other financial ratios;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">a discussion of any material United States federal income tax considerations applicable to the
debt securities;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">information describing any book-entry features;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">provisions for a sinking fund purchase or other analogous fund, if any;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the denominations in which we will issue the series of debt securities;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the currency of payment of debt securities if other than U.S. dollars and the manner of determining
the equivalent amount in U.S. dollars; and</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any other specific terms, preferences, rights or limitations of, or restrictions on, the debt securities,
including any additional events of default or covenants provided with respect to the debt securities, and any terms that may be
required by us or advisable under applicable laws or regulations.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_010"></A>DESCRIPTION OF WARRANTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following description,
together with the additional information we may include in any applicable prospectus supplement, summarizes the material terms
and provisions of the warrants that we may offer under this prospectus and any related warrant agreement and warrant certificate.
While the terms summarized below will apply generally to any warrants that we may offer, we will describe the specific terms of
any series of warrants in more detail in the applicable prospectus supplement. If we indicate in the prospectus supplement, the
terms of any warrants offered under that prospectus supplement may differ from the terms described below. Specific warrant agreements
will contain additional important terms and provisions and will be incorporated by reference as an exhibit to the registration
statement which includes this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue warrants
for the purchase of common stock in one or more series. We may issue warrants independently or together with common stock, and
the warrants may be attached to or separate from common stock. We may issue the warrants under warrant agreements to be entered
into between us and a bank or trust company, as warrant agent, all as described in the prospectus supplement. If we issue the warrants
under warrant agreements, the warrant agent will act solely as our agent in connection with the warrants and will not assume any
obligation or relationship of agency or trust for or with any holders or beneficial owners of warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While the terms summarized
below will apply generally to any warrants that we may offer, we will describe the particular terms of any series of warrants in
more detail in the applicable prospectus supplement. The terms of any warrants offered under a prospectus supplement may differ
from the terms described below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the offering price and aggregate number of warrants offered;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">if applicable, the designation and terms of the securities with which the warrants are issued and
the number of warrants issued with each such security;&#9;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">if applicable, the date on and after which the warrants and the related securities will be separately
transferable;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">in the case of warrants to purchase common stock, the number or amount of shares of common stock
purchasable upon the exercise of one warrant and the price at which and currency in which these shares may be purchased upon such
exercise;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the manner of exercise of the warrants, including any cashless exercise rights;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the warrant agreement under which the warrants will be issued;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the effect of any merger, consolidation, sale or other disposition of our business on the warrant
agreement and the warrants;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">anti-dilution provisions of the warrants, if any;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the terms of any rights to redeem or call the warrants;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any provisions for changes to or adjustments in the exercise price or number of securities issuable
upon exercise of the warrants;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the dates on which the right to exercise the warrants will commence and expire or, if the warrants
are not continuously exercisable during that period, the specific date or dates on which the warrants will be exercisable;&#9;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the manner in which the warrant agreement and warrants may be modified;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the identities of the warrant agent and any calculation or other agent for the warrants;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">federal income tax consequences of holding or exercising the warrants;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the terms of the securities issuable upon exercise of the warrants;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any securities exchange or quotation system on which the warrants or any securities deliverable
upon exercise of the warrants may be listed or quoted; and</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any other specific terms, preferences, rights or limitations of or restrictions on the warrants.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Before exercising their
warrants, holders of warrants will not have any of the rights of holders of the securities purchasable upon such exercise, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">in the case of warrants to purchase common stock the right to receive dividends, if any, or, payments
upon our liquidation, dissolution or winding up or to exercise voting rights, if any.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exercise of Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each warrant will entitle
the holder to purchase the securities that we specify in the applicable prospectus supplement at the exercise price that we describe
in the applicable prospectus supplement. Holders of the warrants may exercise the warrants at any time up to the close of business
on the expiration date that we set forth in the applicable prospectus supplement. After the close of business on the expiration
date, unexercised warrants will become void.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Holders of the warrants
may exercise the warrants by delivering the warrant certificate representing the warrants to be exercised together with specified
information, and paying the required exercise price by the methods provided in the applicable prospectus supplement. We will set
forth on the reverse side of the warrant certificate, and in the applicable prospectus supplement, the information that the holder
of the warrant will be required to deliver to the warrant agent or any other office indicated in the prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon receipt of the
required payment and the warrant certificate properly completed and duly executed at the corporate trust office of the warrant
agent or any other office indicated in the applicable prospectus supplement, we will issue and deliver the securities purchasable
upon such exercise. If fewer than all of the warrants represented by the warrant certificate are exercised, then we will issue
a new warrant certificate for the remaining amount of warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Enforceability of Rights By Holders of Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any warrant agent will
act solely as our agent under the applicable warrant agreement and will not assume any obligation or relationship of agency or
trust with any holder of any warrant. A single bank or trust company may act as warrant agent for more than one issue of warrants.
A warrant agent will have no duty or responsibility in case of any default by us under the applicable warrant agreement or warrant,
including any duty or responsibility to initiate any proceedings at law or otherwise, or to make any demand upon us. Any holder
of a warrant may, without the consent of the related warrant agent or the holder of any other warrant, enforce by appropriate legal
action the holder&rsquo;s right to exercise, and receive the securities purchasable upon exercise of, its warrants in accordance
with their terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Warrant Agreement Will Not Be Qualified Under Trust Indenture
Act</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No warrant agreement
will be qualified as an indenture, and no warrant agent will be required to qualify as a trustee, under the Trust Indenture Act.
Therefore, holders of warrants issued under a warrant agreement will not have the protection of the Trust Indenture Act with respect
to their warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Governing Law</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless we provide otherwise
in the applicable prospectus supplement, each warrant agreement and any warrants issued under the warrant agreements will be governed
by New York law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_011"></A>DESCRIPTION OF RIGHTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue rights
to purchase our common stock or preferred stock, in one or more series. Rights may be issued independently or together with any
other offered security and may or may not be transferable by the person purchasing or receiving the subscription rights. In connection
with any rights offering to our stockholders, we may enter into a standby underwriting arrangement with one or more underwriters
pursuant to which such underwriters will purchase any offered securities remaining unsubscribed after such rights offering. In
connection with a rights offering to our stockholders, we will distribute certificates evidencing the rights and a prospectus supplement
to our stockholders on the record date that we set for receiving rights in such rights offering. The applicable prospectus supplement
or free writing prospectus will describe the following terms of rights in respect of which this prospectus is being delivered:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the title of such rights;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the securities for which such rights are exercisable;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the exercise price for such rights;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the date of determining the security holders entitled to the rights distribution;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the number of such rights issued to each security holder;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the extent to which such rights are transferable;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">if applicable, a discussion of the material United States federal income tax considerations applicable to the issuance or exercise of such rights;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">the date on which the right to exercise such rights shall commence, and the date on which such rights shall expire (subject to any extension);</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">the conditions to completion of the rights offering;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">any provisions for changes to or adjustments in the exercise price or number of securities issuable upon exercise of the rights;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">the extent to which such rights include an over-subscription privilege with respect to unsubscribed securities;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">if applicable, the material terms of any standby underwriting or other purchase arrangement that we may enter into in connection with the rights offering; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">any other terms of such rights, including terms, procedures and limitations relating to the exchange and exercise of such rights.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each right will entitle
the holder thereof the right to purchase for cash such amount of shares of common stock or preferred stock, or any combination
thereof, at such exercise price as shall in each case be set forth in, or be determinable as set forth in, the prospectus supplement
relating to the rights offered thereby. Rights may be exercised at any time up to the close of business on the expiration date
for such rights set forth in the prospectus supplement. After the close of business on the expiration date, all unexercised rights
will become void. Rights may be exercised as set forth in the prospectus supplement relating to the rights offered thereby. Upon
receipt of payment and the proper completion and due execution of the rights certificate at the office of the rights agent, if
any, or any other office indicated in the prospectus supplement, we will forward, as soon as practicable, the shares of common
stock and/or preferred stock purchasable upon such exercise. We may determine to offer any unsubscribed offered securities directly
to persons other than stockholders, to or through agents, underwriters or dealers or through a combination of such methods, including
pursuant to standby underwriting arrangements, as set forth in the applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_012"></A>DESCRIPTION OF UNITS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue units
comprised of one or more of the other securities described in this prospectus in any combination. Each unit will be issued so that
the holder of the unit is also the holder, with the rights and obligations of a holder, of each security included in the unit.
The unit agreement under which a unit is issued may provide that the securities included in the unit may not be held or transferred
separately, at any time or at any time before a specified date or upon the occurrence of a specified event or occurrence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The applicable prospectus
supplement will describe:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the designation and terms of the units and of the securities comprising the units, including whether
and under what circumstances those securities may be held or transferred separately;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any unit agreement under which the units will be issued;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any provisions for the issuance, payment, settlement, transfer or exchange of the units or of the
securities comprising the units; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">whether the units will be issued in fully registered or global form.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_013"></A>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may sell the securities
being offered pursuant to this prospectus to or through underwriters, through dealers, through agents, or directly to one or more
purchasers or through a combination of these methods. The applicable prospectus supplement will describe the terms of the offering
of the securities, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the name or names of any underwriters, if any, and if required, any dealers or agents;&#9;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the purchase price of the securities and the proceeds we will receive from the sale;&#9;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any underwriting discounts and other items constituting underwriters&rsquo; compensation;&#9;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any discounts or concessions allowed or reallowed or paid to dealers; and&#9;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any securities exchange or market on which the securities may be listed or traded.&#9;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may distribute the securities from time
to time in one or more transactions at:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">a fixed price or prices, which may be changed;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">market prices prevailing at the time of sale;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">prices related to such prevailing market prices; or</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">negotiated prices.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Sales Through Underwriters or Dealers</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Only underwriters named
in the prospectus supplement are underwriters of the securities offered by the prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If underwriters are
used in an offering, we will execute an underwriting agreement with such underwriters and will specify the name of each underwriter
and the terms of the transaction (including any underwriting discounts and other terms constituting compensation of the underwriters
and any dealers) in a prospectus supplement. The securities may be offered to the public either through underwriting syndicates
represented by managing underwriters or directly by one or more investment banking firms or others, as designated. If an underwriting
syndicate is used, the managing underwriter(s) will be specified on the cover of the prospectus supplement. If underwriters are
used in the sale, the offered securities will be acquired by the underwriters for their own accounts and may be resold from time
to time in one or more transactions, including negotiated transactions, at a fixed public offering price or at varying prices determined
at the time of sale. Any public offering price and any discounts or concessions allowed or reallowed or paid to dealers may be
changed from time to time. Unless otherwise set forth in the prospectus supplement, the obligations of the underwriters to purchase
the offered securities will be subject to conditions precedent and the underwriters will be obligated to purchase all of the offered
securities, if any are purchased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may grant to the
underwriters options to purchase additional securities to cover over-allotments, if any, at the public offering price, with additional
underwriting commissions or discounts, as may be set forth in a related prospectus supplement. The terms of any over-allotment
option will be set forth in the prospectus supplement for those securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we use a dealer
in the sale of the securities being offered pursuant to this prospectus or any prospectus supplement, we will sell the securities
to the dealer, as principal. The dealer may then resell the securities to the public at varying prices to be determined by the
dealer at the time of resale. The names of the dealers and the terms of the transaction will be specified in a prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Direct Sales and Sales Through Agents</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may sell the securities
directly or through agents we designate from time to time. We will name any agent involved in the offering and sale of securities
and we will describe any commissions we will pay the agent in the prospectus supplement. Unless the prospectus supplement states
otherwise, any agent will act on a best-efforts basis for the period of its appointment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may sell the securities
directly to institutional investors or others who may be deemed to be underwriters within the meaning of the Securities Act with
respect to any sale of those securities. The terms of any such sales will be described in the prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Delayed Delivery Contracts</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may authorize agents
or underwriters to solicit offers by institutional investors to purchase securities from us at the public offering price set forth
in the prospectus supplement pursuant to delayed delivery contracts providing for payment and delivery on a specified date in the
future. We will describe the conditions to these contracts and the commissions we must pay for solicitation of these contracts
in the prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>General Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
the sale of the securities, underwriters, dealers or agents may receive compensation from us or from purchasers of the securities
for whom they act as agents, in the form of discounts, concessions or commissions. Underwriters may sell the securities to or through
dealers, and those dealers may receive compensation in the form of discounts, concessions or commissions from the underwriters
or commissions from the purchasers for whom they may act as agents. Underwriters, dealers and agents that participate in the distribution
of the securities, and any institutional investors or others that purchase securities directly for the purpose of resale or distribution,
may be deemed to be underwriters, and any discounts or commissions received by them from us and any profit on the resale of the
common stock by them may be deemed to be underwriting discounts and commissions under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may provide agents,
underwriters and other purchasers with indemnification against particular civil liabilities, including liabilities under the Securities
Act, or contribution with respect to payments that the agents, underwriters or other purchasers may make with respect to such liabilities.
Agents and underwriters may engage in transactions with, or perform services for, us in the ordinary course of business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To facilitate the public
offering of a series of securities, persons participating in the offering may engage in transactions that stabilize, maintain,
or otherwise affect the market price of the securities. This may include over-allotments or short sales of the securities, which
involves the sale by persons participating in the offering of more securities than have been sold to them by us. In those circumstances,
such persons would cover such over-allotments or short positions by purchasing in the open market or by exercising the over-allotment
option granted to those persons. In addition, those persons may stabilize or maintain the price of the securities by bidding for
or purchasing securities in the open market or by imposing penalty bids, whereby selling concessions allowed to underwriters or
dealers participating in any such offering may be reclaimed if securities sold by them are repurchased in connection with stabilization
transactions. The effect of these transactions may be to stabilize or maintain the market price of the securities at a level above
that which might otherwise prevail in the open market. Such transactions, if commenced, may be discontinued at any time. We make
no representation or prediction as to the direction or magnitude of any effect that the transactions described above, if implemented,
may have on the price of our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise specified
in the applicable prospectus supplement, any common stock sold pursuant to a prospectus supplement will be eligible for listing
on the NYSE American, subject to official notice of issuance. Any underwriters to whom securities are sold by us for public offering
and sale may make a market in the securities, but such underwriters will not be obligated to do so and may discontinue any market
making at any time without notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_014"></A>LEGAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The validity of the
issuance of the securities offered hereby will be passed upon for us by FLANGAS LAW GROUP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_015"></A>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The consolidated balance
sheets of China Pharma Holdings, Inc. and it subsidiaries as of December 31, 2019 and 2018, the related consolidated statements
of operations and comprehensive income (loss), stockholders&rsquo; equity, and cash flows for each of the two years in the period
ended December 31, 2019, and the related notes (collectively referred to as the &ldquo;financial statements&rdquo;), incorporated
in this prospectus by reference to our Annual Report on Form 10-K for the year ended December 31, 2019, have been so incorporated
in reliance upon the report of BF Borgers CPA, P.C., an independent registered public accounting firm, given on the authority of
such firm as experts in accounting and auditing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_016"></A>WHERE YOU CAN FIND MORE INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a public company
and file annual, quarterly and special reports, proxy statements and other information with the SEC. You may read and copy any
document we file at the SEC&rsquo;s public reference room at 100 F Street, NE, Washington, D.C. 20549. You can request copies
of these documents by writing to the SEC and paying a fee for the copying cost. Please call the SEC at 1-800-SEC-0330 for more
information about the operation of the public reference room. Our SEC filings are also available, at no charge, to the public
at the SEC&rsquo;s web site at http://www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_017"></A>INCORPORATION OF CERTAIN INFORMATION
BY REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following documents
filed by us with the Securities and Exchange Commission are incorporated by reference in this prospectus:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1106644/000121390020008020/f10k2019_chinapharmahold.htm">Form 10-K</A> for the fiscal year ended December 31, 2019, filed on March 30, 2020;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1106644/000121390020036919/f10q0920_chinapharmahold.htm">Form 10-Q</A> for the fiscal quarter ended September 30, 2020, filed on November
13, 2020;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1106644/000121390020021867/f10q0620_chinapharmaholdings.htm">Form 10-Q</A> for the fiscal quarter ended June 30, 2020, filed on August 13, 2020;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1106644/000121390020012258/f10q0320_chinapharmaholdings.htm">Form 10-Q</A> for the fiscal quarter ended March 31, 2020, filed on May 14, 2020;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Current Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1106644/000121390020045181/ea132375-8k_chinapharma.htm">Form 8-K</A>, filed on December 29, 2020;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Definitive Proxy Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1106644/000121390020037345/ea129945-def14a_chinapharma.htm">Schedule 14A</A>, filed with the SEC on November 16, 2020;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">The description of our common stock contained in the Registration Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1106644/000101054909000661/cph812b092809.htm">Form 8-A12B</A> filed
pursuant to Section 12 of the Exchange Act on September 28, 2009, including any amendment or report filed with the Commission for
the purpose of updating this description ; and</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">All of our filings made with the Securities and Exchange Commission pursuant to the Exchange Act
after the date of the initial registration statement of which this prospectus forms a part and prior to the effectiveness of the
registration statement of which this prospectus forms a part.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All documents subsequently
filed with the Securities and Exchange Commission by us pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, after
the date of this prospectus and prior to the filing of a post-effective amendment which indicates that all securities offered herein
have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein
and to be part of this prospectus from the respective dates of filing of such documents. Any statement contained herein or in a
document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes
hereof or of the related prospectus supplement to the extent that a statement contained herein or in any other subsequently filed
document which is also incorporated or deemed to be incorporated herein modifies or supersedes such statement. Any such statement
so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>We will provide
to each person, including any beneficial owner, to whom a prospectus is delivered, a copy of any or all of the information that
has been incorporated by reference in the prospectus but not delivered with the prospectus. You may request a copy of these filings,
excluding the exhibits to such filings which we have not specifically incorporated by reference in such filings, at no cost, by
writing us at China Pharma Holdings, Inc., 2nd Floor, No. 17, Jinpan Road, Haikou, Hainan Province, China, or calling us at 86-10-898-66811730.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus is
part of a registration statement we filed with the Securities and Exchange Commission. You should only rely on the information
or representations contained in this prospectus and any accompanying prospectus supplement. We have not authorized anyone to provide
information other than that provided in this prospectus and any accompanying prospectus supplement. We are not making an offer
of these securities in any state where the offer is not permitted. You should not assume that the information in this prospectus
or any accompanying prospectus supplement is accurate as of any date other than the date on the front of the document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CHINA PHARMA HOLDINGS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">$50,000,000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Common Stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Preferred Stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Debt Securities</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Warrants</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Rights</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Units</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 35%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this prospectus is _____________,
2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 14. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The estimated expenses
payable by the Registrant in connection with the issuance and distribution of the securities being registered are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left">SEC Registration Fee</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">5,455</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Legal Fees and Expenses*</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Accounting Fees and Expenses*</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Printing and miscellaneous Expenses*</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">5,455</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">* Estimated expenses are presently not known and cannot be estimated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 15. INDEMNIFICATION OF DIRECTORS AND OFFICERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Nevada Revised
Statutes permits our board of directors to indemnify any person against expenses (including attorneys&rsquo; fees), judgments,
fines, and amounts paid in settlement actually and reasonably incurred by him or her in connection with any threatened, pending,
or completed action, suit, or proceeding in which such person is made a party by reason of his or her being or having been a director,
officer, employee, or agent of us, or serving or having served, at our request, as a director, officer, employee, or agent of another
corporation, partnership, joint venture, trust, or other enterprise, in terms sufficiently broad to permit such indemnification
under certain circumstances for liabilities (including reimbursement for expenses incurred) arising under the Securities Act. The
statute provides that indemnification pursuant to its provisions is not exclusive of other rights of indemnification to which a
person may be entitled under any bylaw, agreement, vote of stockholders or disinterested directors, or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have adopted provisions
in our Articles of Incorporation, as amended from time to time that limit or eliminate the personal liability of our directors
and officers to the fullest extent permitted by Nevada law, as it now exists or may in the future be amended, and against all expenses
and liabilities reasonably incurred in connection with their service for or on behalf of the company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At present, we are not aware of any pending or threatened litigation
or proceeding involving any of our directors, officer, employees or agents in which indemnification would be required or permitted.
We believe provisions in our articles of incorporation are necessary to attract and retain qualified persons as directors and officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In any underwriting
agreement we enter into in connection with the sale of common stock and warrants being registered hereby, the underwriters will
agree to indemnify, under certain conditions, us, our directors, our officers and persons who control us within the meaning of
the Securities Act, against certain liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant
pursuant to the foregoing provisions, the Company has been informed that in the opinion of the Securities and Exchange Commission
such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 16. Exhibits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 10%; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Exhibit</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 88%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Number</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Description of Document</B></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: top">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">1.1*</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Form of underwriting agreement with respect to common stock, preferred stock, debt securities, warrants, rights and/or units.</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: top">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: top; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1106644/000101054913000005/cphi8kex31010413.htm"><FONT STYLE="font-size: 10pt">Articles of Incorporation of the Company (incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K filed on December 31, 2012).</FONT></A></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: top">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">3.2</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: top; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1106644/000101054913000005/cphi8kex32010413.htm"><FONT STYLE="font-size: 10pt">Bylaws of the Company (incorporated by reference to Exhibit 3.2 to our Current Report on Form 8-K filed on December 31, 2012).</FONT></A></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: top; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1106644/000101054909000859/cphs3ex41122209.htm"><FONT STYLE="font-size: 10pt">Specimen of Common Stock Certificate (incorporated by reference to Exhibit 4.1 to our Registration Statement on Form S-3 filed on December 28, 2009).</FONT></A></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">4.2**</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: top; font-size: 10pt"><A HREF="ea132953ex4-2_chinapharma.htm"><FONT STYLE="font-size: 10pt">Form of Indenture, including form of Note</FONT></A></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: top">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">4.3*</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Form of warrant agreement and warrant certificate, if any.</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">4.4*</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Form of unit agreement and unit certificate, if any.</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">4.5*</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Form of Rights Certificate</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: top">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">5.1** </FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: top; font-size: 10pt"><A HREF="ea132953ex5-1_chinapharma.htm"><FONT STYLE="font-size: 10pt">Opinion
of FLANGAS LAW GROUP as to the legality of the securities being registered.</FONT></A></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">23.1**</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: top; font-size: 10pt"><A HREF="ea132953ex5-1_chinapharma.htm"><FONT STYLE="font-size: 10pt">Consent of FLANGAS LAW GROUP (included in Exhibit 5.1).</FONT></A></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">23.2**</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: top; font-size: 10pt"><A HREF="ea132953ex23-2_chinapharma.htm"><FONT STYLE="font-size: 10pt">Consent of BF Borgers CPA, P.C., an independent registered accounting firm.</FONT></A></TD></TR>
</TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">*</TD><TD STYLE="text-align: justify">To the extent applicable, to be filed by a post-effective amendment or as an exhibit to a document filed under the Securities
Exchange Act, as amended, and incorporated by reference herein.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">**</TD><TD>Filed herewith.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 17. UNDERTAKINGS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(a) The undersigned registrant hereby undertakes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(1) To file, during
any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) To include any prospectus
required by Section 10(a)(3) of the Securities Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) To reflect in the
prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the
registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar
value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated
maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the
aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth
in the &ldquo;Calculation of Registration Fee&rdquo; table in the effective registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii) To include any
material information with respect to the plan of distribution not previously disclosed in the registration statement or any material
change to such information in the registration statement; <I>provided, however</I>, that paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii)
of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained
in reports filed with or furnished to the Commission by the registrant pursuant to Section 13 or Section 15(d) of the Exchange
Act that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to
Rule 424(b) that is part of the registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(2) That, for the purpose
of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the
initial <I>bona fide</I> offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(3) To remove from
registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination
of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(4) That, for the purpose
of determining liability under the Securities Act to any purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(A) Each prospectus
filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the
filed prospectus was deemed part of and included in this Registration Statement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(B) Each prospectus
required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B
relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required
by Section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the
earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities
in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that
is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to
the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time
shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement
or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference
into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of
contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or
prospectus that was part of this Registration Statement or made in any such document immediately prior to such effective date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(5) That, for the purpose
of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of the securities:
The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this Registration
Statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or
sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser
and will be considered to offer or sell such securities to such purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) Any preliminary prospectus
or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) Any free-writing
prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned
registrant;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii) The portion of
any other free-writing prospectus relating to the offering containing material information about the undersigned registrant or
its securities provided by or on behalf of the undersigned registrant; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iv) Any other communication
that is an offer in the offering made by the undersigned registrant to the purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(b) The undersigned registrant hereby undertakes
that, for purposes of determining any liability under the Securities Act, each filing of the registrant&rsquo;s annual report pursuant
to Section 13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan&rsquo;s annual report
pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed
to be a new registration statement relating to the securities offered herein, and the offering of such securities at that time
shall be deemed to be the initial <I>bona fide</I> offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(c) Insofar as indemnification for liabilities
arising under the Securities Act, as amended, may be permitted to directors, officers and controlling persons of the registrant
pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification
is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling
person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or
controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel
the matter has been settled by controlling precedent submit to a court of appropriate jurisdiction the question whether such indemnification
by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(d) The undersigned registrant hereby further
undertakes that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(1) For purposes of
determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this Registration
Statement in reliance under Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1)
or (4), or 497(h) under the Securities Act shall be deemed to be part of this Registration Statement as of the time it was declared
effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(2) For the purpose
of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be
deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that
time shall be deemed to be the initial bona fide offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned,
thereunto duly authorized in Hainan, PRC on January 8, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="background-color: white">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Date: January 8, 2021</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>CHINA PHARMA HOLDINGS, INC.</B></FONT></TD></TR>
<TR STYLE="background-color: white">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="background-color: white">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="width: 35%; border-bottom: black 1.5pt solid; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">/s/ Zhilin Li</FONT></TD></TR>
<TR STYLE="background-color: white">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Name: </FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Zhilin Li</FONT></TD></TR>
<TR STYLE="background-color: white">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
<TR STYLE="background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">(principal executive officer)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the
dates indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="width: 24%; border-bottom: black 1.5pt solid; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Signature</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 56%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">Title</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 18%; border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">Date</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">/s/ Zhilin Li</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">Chairman of the Board, President, Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">January 8, 2021</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Zhilin Li</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(principal executive officer) and</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Interim Chief Financial Officer<BR>
        (principal financial officer and principal accounting officer)</P></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">/s/ Heung Mei Tsui</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">January 8, 2021</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Heung Mei Tsui</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">/s/ Gene Michael Bennett</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">January 8, 2021</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Gene Michael Bennett</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">/s/ Yingwen Zhang</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">January 8, 2021</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Yingwen Zhang</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">/s/ Baowen Dong</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">January 8, 2021</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Baowen Dong</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">II-5</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>2
<FILENAME>ea132953ex4-2_chinapharma.htm
<DESCRIPTION>FORM OF INDENTURE, INCLUDING FORM OF NOTE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">INDENTURE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Dated as of ____________, 20__</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Between</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">China Pharma Holdings, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">as Issuer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">And</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[__________________________],</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">as Trustee</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Debt Securities</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">TABLE OF CONTENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 12%">&nbsp;</TD>
    <TD STYLE="width: 73%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE I</B></FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>DEFINITIONS AND INCORPORATION BY REFERENCE</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 1.01.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Definitions</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 1.02.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other Definitions</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 1.03</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Incorporation by Reference of Trust Indenture Act</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 1.04</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rules of Construction</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE II</B></FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>THE SECURITIES</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 2.01</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Unlimited in Amount, Issuable in Series, Form and Dating</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 2.02</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Execution and Authentication</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 2.03</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registrar and Paying Agent</B></FONT></TD>
    <TD STYLE="text-align: center">7</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 2.04</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Paying Agent to Hold Assets in Trust</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 2.05</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Holder Lists</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 2.06</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration of Transfer and Exchange</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 2.07</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Replacement Securities</B></FONT></TD>
    <TD STYLE="text-align: center">8</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 2.08</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Outstanding Securities</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 2.09</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Treasury Securities</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 2.10</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Temporary Securities</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 2.11</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cancellation</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 2.12</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CUSIP Numbers</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 2.13</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Defaulted Interest</B></FONT></TD>
    <TD STYLE="text-align: center">9</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 2.14</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Special Record Dates</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE III</B></FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>REDEMPTION</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 3.01</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notices to Trustee</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 3.02</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Selection of Securities to Be Redeemed</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 3.03</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notice of Redemption</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 3.04</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Effect of Notice of Redemption</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 3.05</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Deposit of Redemption Price</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 3.06</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Securities Redeemed in Part</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE IV</B></FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>COVENANTS</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 4.01</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Payment of Securities</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 4.02</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maintenance of Office or Agency</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 4.03</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SEC Reports</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 4.04</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compliance Certificate</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 4.05</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Taxes</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 4.06</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate Existence</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE V</B></FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>MERGER, ETC.</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 5.01</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>When Company May Merge, etc.</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 5.02</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Successor Corporation Substituted</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE VI</B></FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>DEFAULTS AND REMEDIES</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="width: 15%">&nbsp;</TD>
    <TD STYLE="width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 6.01</B></FONT></TD>
    <TD STYLE="width: 65%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Events of Default</B></FONT></TD>
    <TD STYLE="text-align: right; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 6.02</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Acceleration</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 6.03</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other Remedies</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 6.04</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Wavier of Past Defaults</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 6.05</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Control by Majority</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 6.06</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Limitation on Suits</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 6.07</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rights of Holders to Receive Payment</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 6.08</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Collection Suit by Trustee</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 6.09</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trustee May File Proofs of Claim</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 6.10</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Priorities</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 6.11.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Undertaking for Costs</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE VII</B></FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>TRUSTEE</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 7.01.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Duties of Trustee</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 7.03.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Individual Rights of Trustee</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 7.04.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trustee&rsquo;s Disclaimer</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 7.05.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notice of Defaults</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 7.06.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Reports by Trustee to Holders</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 7.07.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compensation and Indemnity</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 7.08.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Replacement of Trustee</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 7.09.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Successor Trustee by Merger, Etc.</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 7.10.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Eligibility; Disqualification</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 7.11.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Preferential Collection of Claims Against the Company</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE VIII</B></FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>DISCHARGE OF INDENTURE</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 8.01.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Satisfaction and Discharge of Indenture</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 8.02.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Application of Trust Funds; Indemnification</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 8.03.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Legal Defeasance of Securities of any Series</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 8.04.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Covenant Defeasance</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 8.05.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Repayment to Company</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE IX</B></FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>AMENDMENTS, SUPPLEMENTS AND WAIVERS</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 9.01.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Without Consent of Holders</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 9.02.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>With Consent of Holders</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 9.03.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compliance with Trust Indenture Act</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 9.04.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Revocation and Effect of Consents</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 9.05.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notation on or Exchange of Securities</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 9.06.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trustee to Sign Amendment, etc.</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE X</B></FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>MISCELLANEOUS</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 10.01.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trust Indenture Act Controls</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 10.02.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notices</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 10.03.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Communication by Holders with Other Holders</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 10.04.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Certificate and Opinion as to Conditions Precedent</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 10.05.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Statements Required in Certificate or Opinion</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 10.06.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rules by Trustee and Agents</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 10.07.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Legal Holidays</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 10.08.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Duplicate Originals</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 10.09.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Governing Law</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 10.10.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No Adverse Interpretation of Other Agreements</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 10.11.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Successors</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 10.12.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Severability</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 10.13.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Counterpart Originals</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">CROSS-REFERENCE TABLE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.75in; width: 90%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 9%">Indenture</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-left: 0">TIA Section</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center">Section</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.75in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0">Section 310 (a)(1)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">7.10</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.75in">(a)(2)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">7.10</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.75in">(a)(3)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">N.A.</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.75in">(a)(4)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">N.A.</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.75in">(a)(5)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">7.10</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.75in">(b)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">7.08; 7.10</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.75in">(c)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">N.A.</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0">Section 311 (a)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">7.11</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.75in">(b)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">7.11</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.75in">(c)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">N.A.</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0">Section 312(a)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">2.05</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.75in">(b)(1)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">N.A.</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.75in">(b)(2)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">7.06</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.75in">(c)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">7.06; 12.02</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.75in">(d)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">7.06</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0">Section 314 (a)(1), (2), (3)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">4.03</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.75in">(a)(4)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">4.04</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.75in">(b)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">N.A.</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.75in">(c)(1)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">10.04</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.75in">(c)(2)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">10.04</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.75in">(c)(3)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">N.A.</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.75in">(d)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">N.A.</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.75in">(e)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">10.05</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.75in">(f)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">N.A.</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0">Section 315 (a)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">7.01(b)</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.75in">(b)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">7.05; 10.02</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.75in">(c)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">7.01(a)</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.75in">(d)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">7.01(c)</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.75in">(e)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6.11</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0">Section 316(a) (last sentence)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">2.09</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.75in">(a)(1)(A)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6.05</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.75in">(a)(1)(B)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6.04</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.75in">(a)(2)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">N.A.</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.75in">(b)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6.07</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.75in">(c)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">9.04</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0">Section 317 (a)(1)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6.08</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.75in">(a)(2)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6.09</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.75in">(b)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">2.04</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0">Section 318 (a)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">10.01</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">N.A. means Not Applicable</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">NOTE: This Cross-Reference Table shall not,
for any purpose, be deemed to be a part of the indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">INDENTURE dated as of __________, 20___,
between China Pharma Holdings, Inc., a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;), as issuer, and [_______________],
a [__________] banking corporation, as Trustee (the &ldquo;<U>Trustee</U>&rdquo;).</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company has duly authorized the execution
and delivery of this Indenture to provide for the issuance from time to time of its debentures, notes or other evidences of indebtedness
to be issued in one or more series (the &ldquo;<U>Securities</U>&rdquo;), as herein provided, up to such principal amount as may
from time to time be authorized in or pursuant to one or more resolutions of the Board of Directors or by supplemental indenture.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each party agrees as follows for the benefit
of the other party and for the equal and ratable benefit of the Holders of each series of the Securities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>ARTICLE I .</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>A
DEFINITIONS AND INCORPORATION BY REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>SECTION 1.01. <U>Definitions</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Affiliate</U>&rdquo; means, when
used with reference to the Company or another person, any person directly or indirectly controlling, controlled by, or under direct
or indirect common control with, the Company or such other person, as the case may be. For the purposes of this definition, &ldquo;control&rdquo;
when used with respect to any specified person means the power to direct or cause the direction of management or policies of such
person, directly or indirectly, whether through the ownership of voting Securities, by contract or otherwise; and the terms &ldquo;Controlling&rdquo;
and &ldquo;controlled&rdquo; have meanings correlative of the foregoing.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Agent</U>&rdquo; means any registrar,
Paying Agent, authenticating agent or co-registrar.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Board of Directors</U>&rdquo; means,
with respect to any person, the Board of Directors of a person or any duly authorized committee of such Board of Directors.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Board Resolution</U>&rdquo; means,
with respect to any person, a copy of a resolution certified by the secretary or an assistant secretary of such person to have
been duly adopted by the Board of Directors of such person or any duly authorized committee thereof and to be in full force and
effect on the date of such certification, and delivered to the Trustee.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Business Day</U>&rdquo; means a
day that is not a Legal Holiday as defined in <U>Section 10.07</U>.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company</U>&rdquo; means the party
named as such in this Indenture, or any other obligor under this Indenture, until a successor replaces it pursuant to this Indenture
and thereafter means the successor.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Consolidated</U>&rdquo; or &ldquo;<U>consolidated</U>&rdquo;
means, when used with reference to any amount, such amount determined on a consolidated basis in accordance with GAAP, after the
elimination of intercompany items.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Consolidated Assets</U>&rdquo; means,
at a particular date, all amounts which would be included under total assets on a consolidated balance sheet of the Company and
its Subsidiaries as at such date, determined in accordance with GAAP.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Corporate Trust Office</U>&rdquo;
means the office of the Trustee at which at any particular time its corporate services business shall be principally administered,
which office at the date of execution of this Indenture is located at [__________________].</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Default</U>&rdquo; means any event
which is, or after notice or lapse of time or both would be, an Event of Default.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Event of Default</U>&rdquo; has
the meaning provided in <U>Section 6.01</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Exchange Act</U>&rdquo; means the
Securities Exchange Act of 1934, as amended any successor Statute.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>GAAP</U>&rdquo; means generally
accepted accounting principles set forth in the opinions and pronouncements of the Accounting Principles Board of the American
Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or in such
other statements by such other entity as have been approved by a significant segment of the accounting profession, which are applicable
from time to time.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Global Security</U>&rdquo; means
a Security issued to evidence all or a part of any series of Securities that is executed by the Company and authenticated and delivered
by the Trustee to a depositary or pursuant to such depositary&rsquo;s instructions, all in accordance with this Indenture and pursuant
to <U>Section 2.01</U>, which shall be registered as to principal and interest in the name of such depositary or its nominee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Holder</U>&rdquo; means the person
in whose name a Security is registered on the registrar&rsquo;s books.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Indebtedness</U>&rdquo; of a Person
means all obligations which would be treated as liabilities upon a balance sheet of such Person prepared on a consolidated basis
in accordance with GAAP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Indenture</U>&rdquo; means this
Indenture, as amended, supplemented or modified from time to time, and shall include the terms of a particular series of Securities
established as contemplated by Section 2.01.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Lien</U>&rdquo; means any lien,
security interest, charge or encumbrance of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Obligations</U>&rdquo; means all
obligations for principal, premium, interest, penalties, fees, indemnifications, reimbursements, damages and other liabilities
payable under the documentation governing any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Officer</U>&rdquo; of any person
means the Chairman of the Board, the Chief Executive Officer, the President, any Vice President, the Treasurer, the Secretary or
the Controller of such person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Officers&rsquo; Certificate</U>&rdquo;
means a certificate signed by two Officers or by an Officer and an Assistant Treasurer, Assistant Secretary or Assistant Controller
of any person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Opinion of Counsel</U>&rdquo; means
a written opinion from legal counsel who is reasonably acceptable to the Trustee. The counsel may be an employee of or counsel
to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Original Issue Discount Security</U>&rdquo;
means any Security which provides that an amount less than its principal amount is due and payable upon acceleration after an Event
of Default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Person</U>&rdquo; or &ldquo;<U>person</U>&rdquo;
means any individual, corporation, partnership, joint venture, trust, association, limited liability company, joint stock company,
trust, unincorporated organization or government or any agency or political subdivision thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Redemption Date</U>&rdquo; means,
with respect to any Security to be redeemed, the date fixed for such redemption pursuant to this Indenture.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Redemption Price</U>&rdquo; has
the meaning provided in <U>Section 3.03</U>.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>SEC</U>&rdquo; means the Securities
and Exchange Commission and any government agency succeeding to its functions.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Securities</U>&rdquo; means the
means the securities authenticated and delivered under this Indenture.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Securities Act</U>&rdquo; means
the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<U>Series</U>&rdquo;
means a series of Securities established pursuant to this Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Subsidiary</U>&rdquo; of any Person
means (i) a corporation a majority of whose capital stock with voting power, under ordinary circumstances, to elect directors is
at the time, directly or indirectly, owned by such Person or by such Person and a subsidiary or subsidiaries of such Person or
by a subsidiary or subsidiaries of such Person or (ii) any other Person (other than a corporation) in which such Person or such
Person and a subsidiary or subsidiaries of such Person or a subsidiary or subsidiaries of such Persons, at the time, directly or
indirectly, own at least a majority voting interest under ordinary circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>TIA</U>&rdquo; means the Trust Indenture
Act of 1939 (15 U.S. Code Section 77aaa-77bbbb), as in effect on the date of this Indenture; <U>provided</U>, <U>however</U>, that
in the event the TIA is amended after such date, &ldquo;<U>TIA</U>&rdquo; means, to the extent required by such amendment, the
Trust Indenture Act of 1939, as so amended.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Trustee</U>&rdquo; means the party
named as such above until a successor becomes such pursuant to this Indenture and thereafter means or includes each party who is
then a trustee hereunder, and if at any time there is more than one such party, &ldquo;<U>Trustee</U>&rdquo; as used with respect
to the Securities of any series means the Trustee with respect to Securities of that series. If Trustees with respect to different
series of Securities are Trustees under this Indenture, nothing herein shall constitute the Trustees co-Trustees of the same trust,
and each Trustee shall be the Trustee of a trust separate and apart from any trust administered by any other Trustee with respect
to a different series of Securities.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Trust Officer</U>&rdquo; means any
officer in the corporate trust department of the Trustee or any other officer of the Trustee assigned by the Trustee to administer
this Indenture.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>U.S. Government Obligations</U>&rdquo;
means (i) direct obligations of the United States of America for the payment of which the full faith and credit of the United States
of America is pledged or (ii) obligations of a person controlled or supervised by and acting as an agency or instrumentality of
the United States of America, the payment of which is unconditionally guaranteed as a full faith and credit obligation by the United
States of America and which in either case, are non-callable at the option of the issuer thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 1.02. <U>Other Definitions</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">Defined in</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid">Term</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Section</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left"><FONT STYLE="font-size: 10pt">&ldquo;<U>Bankruptcy Law</U>&rdquo;</FONT></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">6.01</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">&ldquo;<U>Custodian</U>&rdquo;</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.01</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&ldquo;<U>Legal Holiday</U>&rdquo;</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10.07</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&ldquo;<U>Paying Agent</U>&rdquo;</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.03</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">&ldquo;<U>Registrar</U>&rdquo;</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.03</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 1.03. <U>Incorporation by Reference
of Trust Indenture Act</U>.</B> Whenever this Indenture refers to a provision of the TIA, the provision is incorporated by reference
in and made a part of this Indenture.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The following TIA terms used in this Indenture
have the following meanings:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>indenture Securities</U>&rdquo;
means the Securities;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>indenture Security holder</U>&rdquo;
means a Holder;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>indenture to be qualified</U>&rdquo;
means this Indenture;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>indenture Trustee</U>&rdquo; or
&ldquo;<U>institutional Trustee</U>&rdquo; means the Trustee; and</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>obligor</U>&rdquo; on the Securities
means the Company and any other obligor on the indenture Securities.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">All other TIA terms used in this Indenture that are defined
by the TIA, defined by TIA reference to another statute or defined by SEC rule have the meanings assigned to them by such definitions.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 1.04. <U>Rules of Construction</U>.</B>
Unless the context otherwise requires: (i) a term has the meaning assigned to it; (ii) an accounting term not otherwise defined
has the meaning assigned to it in accordance with GAAP; (iii) &ldquo;or&rdquo; is not exclusive; (iv) words in the singular include
the plural, and in the plural include the singular; (v) provisions apply to successive events and transactions; and (vi) statements
relating to the payment of principal and interest shall include the payment, premium (if any) and interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 2.01. <U>Unlimited in Amount, Issuable
in Series, Form and Dating</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The aggregate principal amount of Securities
which may be authenticated and delivered under this Indenture is unlimited. The Securities may be issued in one or more series.
There shall be established pursuant to a Board Resolution or an Officers&rsquo; Certificate pursuant to authority granted under
a Board Resolution or established in one or more indentures supplemental hereto, prior to the issuance of Securities of any series:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a) The
title, ranking and authorized denominations of such Securities;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b) The
aggregate principal amount of such Securities and any limit on such aggregate principal amount;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(c) The
price (expressed as a percentage of the principal amount thereof) at which such Securities will be issued and, if other than the
principal amount thereof, the portion of the principal amount thereof payable upon declaration of acceleration of the maturity
thereof;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(d) The
date or dates, or the method for determining such date or dates, on which the principal of such Securities will be payable;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(e) The
rate or rates (which may be fixed or variable), or the method by which such rate or rates shall be determined, at which such Securities
will bear interest, if any;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(f) The
date or dates, or the method for determining such date or dates, from which any such interest will accrue, the dates on which any
such interest will be payable, the record dates for such interest payment dates, or the method by which such dates shall be determined,
the persons to whom such interest shall be payable, and the basis upon which interest shall be calculated if other than that of
a 360-day year of twelve 30-day months;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(g) The
place or places where the principal of and interest, if any, on such Securities will be payable, where such Securities may be surrendered
for registration of transfer or exchange and where notices or demands to or upon the Company in respect of such Securities and
this Indenture may be served;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(h) The
period or periods, if any, within which, the price or prices at which and the other terms and conditions upon which such Securities
may, pursuant to any optional or mandatory redemption provisions, be redeemed, as a whole or in part, at the option of the Company;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i) The
obligation, if any, of the Company to redeem, repay or purchase such Securities pursuant to any sinking fund or analogous provision
or at the option of a holder thereof, and the period or periods within which, the price or prices at which and the other terms
and conditions upon which such Securities will be redeemed, repaid or purchased, as a whole or in part, pursuant to such obligation;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(j) If
other than U.S. dollars, the currency or currencies in which such Securities are denominated and payable, which may be a foreign
currency or units of two or more foreign currencies or a composite currency or currencies, and the terms and conditions relating
thereto;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(k) Whether
the amount of payments of principal of (and premium, if any) or interest, if any, on such Securities may be determined with reference
to an index, formula or other method (which index, formula or method may, but need not be, based on the yield on or trading price
of other Securities, including United States Treasury Securities, or on a currency, currencies, currency unit or units, or composite
currency or currencies) and the manner in which such amounts shall be determined;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(l) Whether
the principal of or interest on the Securities of the series is to be payable, at the election of the Company or a holder thereof,
in a currency or currencies, currency unit or units or composite currency or currencies other than that in which such Securities
are denominated or stated to be payable, the period or periods within which, and the terms and conditions upon which, such election
may be made, and the time and manner of, and identity of the exchange rate agent with responsibility for, determining the exchange
rate between the currency or currencies, currency unit or units or composite currency or currencies in which such Securities are
denominated or stated to be payable and the currency or currencies, currency unit or units or composite currency or currencies
in which such Securities are to be so payable;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(m) Provisions,
if any, granting special rights to the holders of Securities of the series upon the occurrence of such events as may be specified;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(n) Any
deletions from, modifications of or additions to the Events of Default or covenants of the Company with respect to Securities of
the series, whether or not such Events of Default or covenants are consistent with the Events of Default or covenants described
herein;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(o) Whether
and under what circumstances the Company will pay any additional amounts on such Securities in respect of any tax, assessment or
governmental charge and, if so, whether the Company will have the option to redeem such Securities in lieu of making such payment;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(p) Whether
Securities of the series are to be issuable as registered Securities, bearer Securities (with or without coupons) or both, any
restrictions applicable to the offer, sale or delivery of bearer Securities and the terms upon which bearer Securities of the series
may be exchanged for registered Securities of the series and vice versa (if permitted by applicable laws and regulations), whether
any Securities of the series are to be issuable initially in temporary global form and whether any Securities of the series are
to be issuable in permanent global form with or without coupons and, if so, whether beneficial owners of interests in any such
permanent Global Security may exchange such interests for Securities of such series and of like tenor or any authorized form and
denomination and the circumstances under which any such exchanges may occur, if other than in the manner provided in this Indenture,
and, if registered Securities of the series are to be issuable as a Global Security, the identity of the depositary for such series;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(q) The
date as of which any bearer Securities of the series and any temporary Global Security representing outstanding Securities of the
series shall be dated if other than the date of original issuance of the first Security of the series to be issued;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(r) The
person to whom any interest on any registered Security of the series shall be payable, if other than the person in whose name that
Security (or one or more predecessor Securities) is registered at the close of business on the regular record date for such interest,
the manner in which, or the person to whom, any interest on any bearer Security of the series shall be payable, if otherwise than
upon presentation and surrender of the coupons appertaining thereto as they severally mature, and the extent to which, or the manner
in which, any interest payable on a temporary Global Security on an interest payment date will be paid if other than in the manner
provided in this Indenture;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(s) Whether
such Securities will be issued in certificated or book entry form;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(t) The
applicability, if any, of the legal defeasance and covenant defeasance provisions of this Indenture to the Securities of the series;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(u) If
the Securities of such series are to be issuable in definitive form (whether upon original issue or upon exchange of a temporary
Security of such series) only upon receipt of certain certificates or other documents or satisfaction of other conditions, then
the form and/or terms of such certificates, documents or conditions;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(v) Whether
the Securities will be listed for trading on an exchange and the identity of such exchange;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(w) Whether
any underwriters will act as market makers for the Securities;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(x) Any
guarantees of such Securities by the Company&rsquo;s Subsidiaries or others;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(y) The
date or dates, if any, after which the Securities may be converted or exchanged into or for shares of the Company&rsquo;s common
stock or another company&rsquo;s securities or properties or cash and the terms for any such conversion or exchange;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(z) Any
other terms of the series.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The Securities of any series shall be substantially
of the tenor and purport as set forth in one or more indentures supplemental hereto or as provided in a written order of the Company,
in each case with such insertions, omission, substitutions and other variations as are required or permitted by this Indenture,
and may have such letters, numbers or other marks of identification or designation and such legends or endorsements printed, lithographed
or engraved thereon as the Company may deem appropriate and as are not inconsistent with the provisions of this Indenture, or as
may be required to comply with any law or with any rule or regulation made pursuant thereto or with any rule or regulation of any
stock exchange on which Securities of that series may be listed or of the depository, or to conform to usage.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The Trustee&rsquo;s Certificate of Authentication
shall be in substantially the following form:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 1in; text-align: justify">&ldquo;This is one of the Securities
of the series designated in accordance with, and referred to in the within-mentioned Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 1in; text-align: justify">Dated:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 1in; text-align: justify">[____________________], as
Trustee</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 1in; text-align: justify">By:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 1in; text-align: justify; text-indent: 0.25in">Authorized
Signatory&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 2.02. <U>Execution and Authentication</U>.</B>
Two Officers shall sign the Securities for the Company by manual or facsimile signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">If an Officer whose signature is on a Security
no longer holds that office at the time the Security is authenticated, the Security shall be valid nevertheless.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">A Security shall not be valid until authenticated
by the manual signature of the Trustee. The signature shall be conclusive evidence that the Security has been authenticated under
this Indenture.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The Trustee shall authenticate Securities
for original issue upon a written order of the Company signed by one Officer of the Company.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The Trustee may appoint an authenticating
agent reasonably acceptable to the Company to authenticate Securities. Unless limited by the terms of such appointment, an authenticating
agent may authenticate Securities whenever the Trustee may do so. Each reference in this Indenture to authentication by the Trustee
includes authentication by such agent. An authenticating agent has the same rights as an Agent to deal with the Company or an Affiliate
of the Company.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">If the Company shall establish pursuant to
<U>Section 2.01</U> that the Securities of a series are to be issued in the form of one or more Global Securities, then the Company
shall execute and the Trustee shall authenticate and deliver one or more Global Securities that (i) shall represent and shall be
denominated in an amount equal to the aggregate principal amount of all of the Securities of such series to be issued in the form
of Global Securities and not yet canceled, (ii) shall be registered in the name of the depositary for such Global Security or Securities
or the nominee of such depositary, (iii) shall be delivered by the Trustee to such depositary or pursuant to such depositary&rsquo;s
instructions, and (iv) shall bear a legend substantially to the following effect: &ldquo;Unless and until it is exchanged in whole
or in part for Securities in definitive registered form, this Security may not be transferred except as a whole by the depositary
to the nominee of the depositary or by a nominee of the depositary to the depositary or another nominee of the depositary or by
the depositary or any such nominee to a successor depositary or a nominee of such successor depositary.&rdquo;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each depositary designated pursuant to <U>Section
2.01</U> must, at the time of its designation and at all times while it services as depositary, be a clearing agency registered
under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 2.03. <U>Registrar and Paying Agent</U>.</B>
The Company shall maintain an office or agency where Securities of a particular series may be presented for registration of transfer
or for exchange (the &ldquo;<U>Registrar</U>&rdquo;) and an office or agency where Securities may be presented for payment (the
&ldquo;<U>Paying Agent</U>&rdquo;). The registrar for a particular series of Securities shall keep a register of the Securities
of that series and of their transfer and exchange. The Company may appoint one or more co-registrars and one or more additional
Paying Agents for each series of Securities. The term &ldquo;Paying Agent&rdquo; includes any additional paying agent and the term
&ldquo;Registrar&rdquo; includes any additional registrar. The Company may change any Paying Agent or registrar without prior notice
to any Holder.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The Company shall enter into an appropriate
agency agreement with any Agent not a party to this Indenture, which shall incorporate the terms of the TIA and implement the terms
of this Indenture which relate to such Agent. The Company shall give prompt written notice to the Trustee of the name and address
of any Agent who is not a party to this Indenture. If the Company fails to appoint or maintain another entity as Registrar or Paying
Agent, the Trustee shall act as such. The Company or any Affiliate of the Company may act as Paying Agent or Registrar.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The Company hereby initially appoints the
Trustee as Registrar and Paying Agent for each series of Securities unless another Registrar or Paying Agent, as the case may be,
is appointed prior to the time the Securities of that series are first issued.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 2.04. <U>Paying Agent to Hold Assets
in Trust</U>.</B> The Company shall require each Paying Agent other than the Trustee to agree in writing that the Paying Agent
shall hold in trust for the benefit of Holders or the Trustee all assets held by the Paying Agent for the payment of principal
of and interest on the Securities (whether such money has been paid to it by the Company or any other obligor on the Securities)
and shall notify the Trustee of any failure by the Company (or any other obligor on the Securities) in making any such payment.
While any such failure continues, the Trustee may require a Paying Agent to pay all money held by it to the Trustee and to account
for any funds disbursed. The Company at any time may require a Paying Agent to pay all money held by it to the Trustee. Upon payment
over to the Trustee, the Paying Agent (if other than the Company or a Subsidiary of the Company) shall have no further liability
for the money so paid over to the Trustee. If the Company or a Subsidiary of the Company acts as Paying Agent, it shall segregate
and hold in a separate trust fund for the benefit of the Holders all money held by it as Paying Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 2.05. <U>Holder Lists</U>.</B>
The Trustee shall preserve in as current a form as is reasonably practicable the most recent list available to it of the names
and addresses of Holders, separately by series, and shall otherwise comply with TIA Section 312(a). If the Trustee is not the registrar,
the Company shall furnish to the Trustee on or before each interest payment date for the Securities and at such other times as
the Trustee may request in writing a list in such form and as of such date as the Trustee may reasonably require of the names and
addresses of Holders, separately by series, relating to such interest payment date or request, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 2.06. <U>Registration of Transfer
and Exchange</U></B>. When Securities of a series are presented to the registrar or a co-registrar with a request to register their
transfer or to exchange them for an equal principal amount of Securities of other denominations, the registrar or co-registrar
shall register the transfer or make the exchange if its requirements for such transaction are met. To permit registrations of transfer
and exchanges, the Company shall issue and the Trustee shall authenticate Securities at the registrar&rsquo;s or co-registrar&rsquo;s
request. No service charge shall be made for any registration of transfer or exchange, but the Company may require payment of a
sum sufficient to cover any tax or other governmental charge that may be imposed in connection with registration, transfer or exchange
of Securities other than exchanges pursuant to <U>Section 2.10</U>, <U>3.06</U> or <U>9.05</U> not involving any transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The registrar or co-registrar shall not be
required to register the transfer or exchange of (i) any Security of a particular series selected for redemption in whole or in
part, except the unredeemed portion of any Security of that series being redeemed in part, or (ii) any Security of a particular
series during a period beginning at the opening of business 15 days before the day of any selection of Securities of that series
for redemption under <U>Section 3.02</U> and ending at the close of business on the date of selection.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">Any Holder of a beneficial interest in a Global
Security shall, by acceptance of such beneficial interest, agree that transfers of beneficial interest in such Global Security
may be effected only through a book entry system maintained by the holder of such Global Security (or its agent), and that ownership
of a beneficial interest in the Security shall be required to be reflected in a book entry system.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 2.07. <U>Replacement Securities</U>.</B>
If a mutilated Security is surrendered to the Trustee or if the Holder of a Security claims that the Security has been lost, destroyed
or wrongfully taken, the Company shall issue and the Trustee shall authenticate a replacement Security of the same series if the
requirements of the Trustee and the Company are met; <U>provided</U> that, if any such Security has been called for redemption
in accordance with the terms thereof, the Trustee may pay the Redemption Price thereof on the Redemption Date without authenticating
or replacing such Security. The Trustee or the Company may, in either case, require the Holder to provide an indemnity bond sufficient
in the judgment of each of the Trustee and the Company to protect the Company, the Trustee or any Agent from any loss which any
of them may suffer if a Security is replaced or if the Redemption Price therefor is paid pursuant to this Section. The Company
may charge the Holder who has lost a Security for its expenses in replacing a Security.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">Every replacement Security is an obligation
of the Company and shall be entitled to the benefits of this Indenture equally and proportionately with any and all other Securities
of the same series.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 2.08. <U>Outstanding Securities</U>.</B>
The Securities of any series outstanding at any time are all the Securities of that series authenticated by the Trustee except
for those canceled by it, those delivered to it for cancellation and those described in this Section as not outstanding.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">If a Security is replaced pursuant to <U>Section
2.07</U>, it ceases to be outstanding and interest ceases to accrue unless the Trustee receives proof satisfactory to it that the
replaced Security is held by a bona fide purchaser.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">If all principal of and interest on any of
the Securities are considered paid under <U>Section 4.01</U>, such Securities shall cease to be outstanding and interest on them
shall cease to accrue.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">Except as provided in <U>Section 2.09</U>,
a Security does not cease to be outstanding because the Company or an Affiliate of the Company holds such Security.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">For each series of Original Issue Discount
Securities, the principal amount of such Securities that shall be deemed to be outstanding and used to determine whether the necessary
Holders have given any request, demand, authorization, direction, notice, consent or waiver, shall be the principal amount of such
Securities that could be declared to be due and payable upon acceleration upon an Event of Default as of the date of such determination.
When requested by the Trustee, the Company will advise the Trustee of such amount, showing its computations in reasonable detail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 2.09. <U>Treasury Securities</U>.</B>
In determining whether the Holders of the required principal amount of Securities of any series have concurred in any direction,
waiver or consent, Securities owned by the Company or an Affiliate of the Company shall be considered as though they are not outstanding,
except that for the purposes of determining whether the Trustee shall be protected in relying on any such direction, waiver or
consent, only Securities which such Trustee actually knows are so owned shall be so disregarded.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 67.5pt"><B>SECTION 2.10. <U>Temporary Securities</U>.</B>
Until definitive Securities are ready for delivery, the Company may prepare and execute and the Trustee shall authenticate temporary
Securities. Temporary Securities shall be substantially in the form of definitive Securities but may have variations that the Company
considers appropriate for temporary Securities. Without unreasonable delay, the Company shall prepare and the Trustee shall authenticate
definitive Securities in exchange for temporary Securities. Holders of temporary Securities shall be entitled to all of the benefits
of this Indenture.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 67.5pt"><B>SECTION 2.11. <U>Cancellation</U>. </B>
The Company at any time may deliver Securities to the Trustee for cancellation. The Registrar and Paying Agent shall forward to
the Trustee any Securities surrendered to them for registration of transfer, exchange, payment or repurchase. The Trustee shall
cancel all Securities surrendered for registration of transfer, exchange, payment, repurchase, redemption, replacement or cancellation
and shall destroy such Securities (subject to the record retention requirements of the Exchange Act). Certification of the destruction
of all cancelled Securities shall be promptly delivered to the Company. The Company may not issue new Securities to replace Securities
that it has paid or that have been delivered to the Trustee for cancellation.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 2.12. <U>CUSIP Numbers</U>.</B>
The Company in issuing the Securities may use &ldquo;CUSIP&rdquo; numbers (if then generally in use), and the Trustee shall use
CUSIP numbers in notices of redemption or exchange as a convenience to Holders; <U>provided</U> that any such notice shall state
that no representation is made as to the correctness of such numbers either as printed on the Securities or as contained in any
such notice and that reliance may be placed only on the other identification numbers printed on the Securities, and any such redemption
shall not be affected by any defect in or omission of such numbers. The Company shall promptly notify the Trustee of any change
in the CUSIP numbers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 67.5pt"><B>SECTION 2.13. <U>Defaulted Interest</U>.
</B> If the Company fails to make a payment of interest on any series of Securities, it shall pay such defaulted interest plus
(to the extent lawful) any interest payable on the defaulted interest, in any lawful manner. It may elect to pay such defaulted
interest, plus any such interest payable on it, to the Persons who are Holders of such Securities on which the interest is due
on a subsequent special record date. The Company shall notify the Trustee in writing of the amount of defaulted interest proposed
to be paid on each such Security. The Company shall fix any such record date and payment date for such payment. At least 15 days
before any such record date, the Company shall mail to Holders affected thereby a notice that states the record date, payment date,
and amount of such interest to be paid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 2.14. <U>Special Record Dates</U>.</B>
The Company may, but shall not be obligated to, set a record date for the purpose of determining the identity of Holders entitled
to consent to any supplement, amendment or waiver permitted by this Indenture. If a record date is fixed, the Holders of Securities
of that series outstanding on such record date, and no other Holders, shall be entitled to consent to such supplement, amendment
or waiver or revoke any consent previously given, whether or not such Holders remain Holders after such record date. No consent
shall be valid or effective for more than 90 days after such record date unless consents from Holders of the principal amount of
Securities of that series required hereunder for such amendment or waiver to be effective shall have also been given and not revoked
within such 90-day period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE III</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">REDEMPTION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 3.01. <U>Notices to Trustee</U>.</B>
If the Company elects to redeem Securities of any series pursuant to any optional redemption provisions thereof, it shall notify
the Trustee of the intended Redemption Date and the principal amount of Securities of that series to be redeemed.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The Company shall give each notice provided
for in this Section and an Officers&rsquo; Certificate at least 45 days before the Redemption Date (unless a shorter period shall
be satisfactory to the Trustee).</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 3.02. <U>Selection of Securities
to Be Redeemed</U>.</B> If fewer than all the Securities of any series are to be redeemed, the Trustee shall select the Securities
of that series to be redeemed from the outstanding Securities of that series to be redeemed by a method that complies with the
requirements of any exchange on which the Securities of that series are listed, or, if the Securities of that series are not listed
on an exchange, on a pro rata basis or by lot, which in any case shall be in accordance with a method the Trustee considers fair
and appropriate.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Except as otherwise provided as to any particular
series of Securities, Securities and portions thereof that the Trustee selects shall be in amounts equal to the minimum authorized
denomination for Securities of the series to be redeemed or any integral multiple thereof. Provisions of this Indenture that apply
to Securities called for redemption also apply to portions of Securities called for redemption. The Trustee shall notify the Company
promptly in writing of the Securities or portions of Securities to be called for redemption.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 3.03. <U>Notice of Redemption</U>.</B>
At least 30 days but not more than 60 days before the Redemption Date, the Company shall mail a notice of redemption by first-class
mail to each Holder whose Securities are to be redeemed at the address of such Holder appearing in the register.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The notice shall identify the Securities of
the series to be redeemed and shall state:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(1) the
Redemption Date;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(2) the
redemption price fixed in accordance with the terms of the Securities of the series to be redeemed, plus accrued interest, if any,
to the date fixed for redemption (the &ldquo;<U>Redemption Price</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(3) if
any Security is being redeemed in part, the portion of the principal amount of such Security to be redeemed and that, after the
Redemption Date, upon surrender of such Security, a new Security or Securities in principal amount equal to the unredeemed portion
will be issued;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(4) the
name and address of the Paying Agent;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(5) that
Securities called for redemption must be surrendered to the Paying Agent to collect the Redemption Price;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(6) that,
unless the Company defaults in payment of the Redemption Price, interest on Securities called for redemption ceases to accrue on
and after the Redemption Date; and</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(7) the
CUSIP number, if any, of the Securities to be redeemed.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">At the Company&rsquo;s written request, the
Trustee shall give the notice of redemption in the Company&rsquo;s name and at its expense. The notice mailed in the manner herein
provided shall be conclusively presumed to have been duly given whether or not the Holder receives such notice. In any case, failure
to give such notice by mail or any defect in the notice to the Holder of any Security shall not affect the validity of the proceeding
for the redemption of any other Security.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 3.04. <U>Effect of Notice of Redemption</U>.</B>
Once notice of redemption is mailed, Securities called for redemption become due and payable on the Redemption Date at the Redemption
Price. Upon surrender to the Paying Agent, such Securities shall be paid at the Redemption Price.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 3.05. <U>Deposit of Redemption
Price</U>.</B> On or before the Redemption Date, the Company shall deposit with the Trustee or with the Paying Agent (or if the
Company or any Subsidiary of the Company is acting as its own Paying Agent, the Company or such Subsidiary shall segregate and
hold in trust) money sufficient to pay the Redemption Price on all Securities to be redeemed on that date other than Securities
or portions thereof called for redemption on that date which have been delivered by the Company to the Trustee for cancellation.
The Paying Agent shall promptly return to the Company any money not required for that purpose.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 3.06. <U>Securities Redeemed in
Part</U>.</B> Upon surrender of a Security that is redeemed in part, the Company shall issue and the Trustee shall authenticate
for the Holder at the expense of the Company, a new Security of the same series equal in principal amount to the unredeemed portion
of the Security surrendered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE IV</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COVENANTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 4.01. <U>Payment of Securities</U>.</B>
The Company shall pay or cause to be paid the principal of and interest on the Securities on the dates and in the manner provided
in this Indenture and the Securities. Principal and interest shall be considered paid on the date due if the Paying Agent, if other
than the Company or an Affiliate, holds as of 11:00 a.m. New York time on that date immediately available funds designated for
and sufficient to pay all principal and interest then due. To the extent lawful, the Company shall pay interest on overdue principal
and overdue installments of interest at the rate per annum borne by the applicable series of Securities.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 4.02. <U>Maintenance of Office
or Agency</U>. </B> The Company shall maintain in the Borough of Manhattan, the City of New York, or in [_______________], an office
or agency (which may be an office of the Trustee or an affiliate of the Trustee or registrar) where Securities may be surrendered
for registration of transfer or exchange and where notices and demands to or upon the Company in respect of the Securities and
this Indenture may be served. The Company shall give prompt written notice to the Trustee of the location, and any change in the
location, of such office or agency. If at any time the Company shall fail to maintain any such required office or agency or shall
fail to furnish the Trustee with the address thereof, such presentations, surrenders, notices and demands may be made or served
at the Corporate Trust Office of the Trustee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 67.5pt">The Company may also from time to time
designate one or more other offices or agencies where the Securities may be presented or surrendered for any or all such purposes
and may from time to time rescind such designations; <U>provided</U>, <U>however</U>, that no such designation or rescission shall
in any manner relieve the Company of its obligation to maintain an office or agency in the Borough of [___________], the City of
[___________], or [___________], for such purposes. The Company shall give prompt written notice to the Trustee of any such designation
or rescission and of any change in the location of any such other office or agency.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The Company hereby designates the Corporate
Trust Office of the Trustee as one such office or agency of the Company in accordance with <U>Section 2.03</U>.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 67.5pt"><B>SECTION 4.03. <U>SEC Reports</U>.</B>
The Company shall deliver to the Trustee within 15 days after it files them with the SEC copies of the annual reports and of the
information, documents, and other reports (or copies of such portions of any of the foregoing as the SEC may by rules and regulations
prescribe) which the Company is required to file with the SEC pursuant to Section 13 or 15(d) of the Exchange Act; provided, however,
the Company shall not be required to deliver to the Trustee any materials for which the Company has sought and received confidential
treatment by the SEC. The Company also shall comply with the other provisions of TIA Section 314 (a).</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 4.04. <U>Compliance Certificate</U>.</B>
The Company shall deliver to the Trustee, within 120 days after the end of each fiscal year of the Company, an Officers&rsquo;
Certificate stating that in the course of the performance by the signers of their duties as officers of the Company, they would
normally have knowledge of any failure by the Company to comply with all conditions, or default by the Company with respect to
any covenants, under this Indenture, and further stating whether or not they have knowledge of any such failure or default and,
if so, specifying each such failure or default and the nature thereof. For purposes of this Section, such compliance shall be determined
without regard to any period of grace or requirement of notice provided for in this Indenture. The certificate need not comply
with <U>Section 10.04</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 4.05. <U>Taxes</U>. </B> The Company
shall pay prior to delinquency, all material taxes, assessments, and governmental levies except as contested in good faith by appropriate
proceedings.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 4.06. <U>Corporate Existence</U>.</B>
Subject to <U>Article V</U> hereof, the Company shall do or cause to be done all things necessary to preserve and keep in full
force and effect (i) its corporate existence and (ii) the material rights (charter and statutory), licenses and franchises of the
Company and its Subsidiaries taken as a whole; <U>provided</U>, <U>however</U>, that the Company shall not be required to preserve
any such right, license or franchise if the Board of Directors or management of the Company shall determine that the preservation
thereof is no longer in the best interests of the Company, and that the loss thereof is not adverse in any material respect to
the Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE V</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MERGER, ETC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 5.01. <U>When Company May Merge,
etc</U>.</B> (a) The Company shall not consolidate or merge with or into, or sell, assign, transfer, lease, convey or otherwise
dispose of all or substantially all of its assets to, any Person unless: (i) the Person formed by or surviving any such consolidation
or merger (if other than the Company), or to which such sale, assignment, transfer, lease, conveyance or disposition has been made,
is a corporation organized and existing under the laws of the United States of America, any state thereof or the District of Columbia;
(ii) the Person formed by or surviving any such consolidation or merger (if other than the Company), or to which such sale, assignment,
transfer, lease, conveyance or disposition has been made, assumes by supplemental indenture satisfactory in form to the Trustee
all the obligations of the Company under the Securities and this Indenture; and (iii) immediately after such transaction, and giving
effect thereto, no Default or Event of Default shall have occurred and be continuing. Notwithstanding the foregoing, the Company
may merge with another Person or acquire by purchase or otherwise all or any part of the property or assets of any other corporation
or Person in a transaction in which the surviving entity is the Company.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b) In
connection with any consolidation, merger, sale, assignment, transfer or lease contemplated by this Section 5.01, the Company shall
deliver, or cause to be delivered, to the Trustee, in form and substance reasonably satisfactory to the Trustee, an Officers&rsquo;
Certificate and an Opinion of Counsel, each stating that such consolidation, merger, sale, assignment, transfer or lease and the
supplemental indenture in respect thereof comply with <U>Article V</U> and the TIA and that all conditions precedent herein provided
for relating to such transaction have been complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 5.02. <U>Successor Corporation
Substituted</U>.</B> Upon any consolidation or merger, or any sale, assignment, transfer, lease, conveyance or other disposition
of all or substantially all the assets of the Company in accordance with <U>Section 5.01</U>, the successor corporation formed
by such consolidation or into which the Company is merged or to which such sale, assignment, transfer, lease, conveyance or other
disposition is made shall succeed to, and be substituted for, and may exercise every right and power of, the Company under this
Indenture with the same effect as if such successor corporation had been named as the Company herein. In the event of any such
sale or conveyance, but not any such lease, the Company or any successor corporation which thereafter shall have become such in
the manner described in this <U>Article V</U> shall be discharged from all obligations and covenants under this Indenture and the
Securities and may be dissolved, wound up or liquidated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE VI</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DEFAULTS AND REMEDIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 6.01. <U>Events of Default</U>.</B>
An &ldquo;Event of Default&rdquo; occurs with respect to Securities of any particular series, unless in the establishing Board
Resolutions, Officers&rsquo; Certificate or supplemental indenture hereto, it is provided that such series shall not have the benefit
of any such Event of Default, when any of the following occurs:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(i) the
Company defaults in the payment of interest on any Security of that series when it becomes due and payable and such default continues
for a period of 30 days;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ii) the
Company defaults in the payment of the principal of any Security of that series when the same becomes due and payable at maturity,
upon acceleration, redemption or otherwise;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(iii) the
Company fails to comply with any of its other agreements or covenants in, or provisions of, the Securities of that series or this
Indenture and the Default continues for the period and after the notice specified below;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(iv) the
Company pursuant to or within the meaning of any Bankruptcy Law: (A) commences a voluntary case or proceeding, (B) consents to
the entry of an order for relief against it in an involuntary case or proceeding, (C) consents to the appointment of a Custodian
of it or for all or substantially all of its property, or (D) makes a general assignment for the benefit of its creditors; or</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(v) a
court of competent jurisdiction enters an order or decree under any Bankruptcy Law that: (A) is for relief against the Company
in an involuntary case or proceeding, (B) appoints a Custodian for the Company or for all or substantially all of the Company&rsquo;s
property, or (C) orders the liquidation of the Company;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">and in case of (v) the order or decree remains unstayed and
in effect for 60 days.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The term &ldquo;<U>Bankruptcy Law</U>&rdquo;
means Title 11 of the U.S. Code or any similar Federal or state law for the relief of debtors. The term &ldquo;<U>Custodian</U>&rdquo;
means any receiver, Trustee, assignee, liquidator, sequestrator or similar official under any Bankruptcy Law.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">A Default under clause (iii) of this Section
6.01 is not an Event of Default with respect to a particular series of Securities until the Trustee notifies the Company in writing,
or the Holders of at least 25% in principal amount of the outstanding Securities of that series notify the Company and the Trustee,
in writing, of the Default, and the Company does not cure the Default within 30 days after receipt of the notice. The notice must
specify the Default, demand that it be remedied and state that the notice is a &ldquo;Notice of Default&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 6.02. <U>Acceleration</U>.</B>
If an Event of Default (other than an Event of Default specified in clause (iv) or (v) of Section 6.01) occurs and is continuing,
the Trustee or the Holders of at least 25% of the principal amount of the outstanding Securities of that series, by written notice
to the Company may declare due and payable 100% of the principal amount (or, in the case of Original Issue Discount Securities,
such lesser amount as may be provided for in such Securities) of the Securities of that series plus any accrued interest to the
date of payment. Upon a declaration of acceleration, such principal (or such lesser amount) and accrued interest to the date of
payment shall be due and payable. If an Event of Default specified in clause (iv) or (v) of Section 6.01 occurs, all unpaid principal
and accrued interest on the Securities shall become and be immediately due and payable without any declaration or other act on
the part of the Trustee or any Holder.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The Holders of a majority of the outstanding
principal amount of the Securities of that series by written notice to the Trustee may rescind an acceleration and its consequences
if (i) all existing Events of Default other than the nonpayment of principal (or such lesser amount) of or interest on the Securities
of that series which have become due solely because of the acceleration, have been cured or waived and (ii) the rescission would
not conflict with any judgment or decree of a court of competent jurisdiction.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 6.03. <U>Other Remedies</U>.</B>
If an Event of Default occurs and is continuing with respect to any series of Securities, the Trustee may pursue any available
remedy by proceeding at law or in equity to collect the payment of principal of or interest on the Securities of that series or
to enforce the performance of any provision of the Securities of that series or this Indenture.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The Trustee may maintain a proceeding even
if it does not possess any of the Securities or does not produce any of them in the proceeding. A delay or omission by the Trustee
or any Holder in exercising any right or remedy accruing upon the Event of Default shall not impair the right or remedy or constitute
a waiver of or acquiescence in the Event of Default. No remedy is exclusive of any other remedy. All remedies are cumulative to
the extent permitted by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 6.04. <U>Waiver of Past Defaults</U>.</B>
Subject to <U>Sections 6.07</U> and <U>9.02</U>, the Holders of at least a majority in principal amount of the outstanding Securities
of any series by notice to the Trustee may waive an existing Default or Event of Default and its consequences with respect to that
series, except a Default in the nonpayment of the principal of or interest on any Security of that series (<U>provided</U>, <U>however</U>,
that the Holders of a majority in principal amount of the then outstanding Securities of any series may rescind an acceleration
and its consequences, including any related payment default that resulted from such acceleration) . When a Default or Event of
Default is waived, it is cured and ceases.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 6.05. <U>Control by Majority</U>.</B>
The Holders of at least a majority in principal amount of the outstanding Securities of any series may direct the time, method
and place of conducting any proceeding for any remedy available to the Trustee or exercising any trust or power conferred on it.
However, the Trustee may refuse to follow any direction that conflicts with law or this Indenture, that the Trustee determines
may be unduly prejudicial to the rights of other Holders or that may involve the Trustee in personal liability. The Trustee may
take any other action which it deems proper which is not inconsistent with any such direction.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 6.06. <U>Limitation on Suits</U>.</B>
A Holder of Securities of any series may not pursue a remedy with respect to this Indenture or the Securities of that series unless:
(i) the Holder gives to the Trustee written notice of a continuing Event of Default with respect to such series; (ii) the Holders
of at least 25% in principal amount of the outstanding Securities of that series make a written request to the Trustee to pursue
the remedy; (iii) such Holder or Holders offer to the Trustee indemnity satisfactory to the Trustee against any loss, liability,
cost or expense; (iv) the Trustee does not comply with the request within 60 days after receipt of the request and the offer of
indemnity; and (v) during such 60-day period the Holders of at least a majority in principal amount of the outstanding Securities
of that series do not give the Trustee a direction inconsistent with the request.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">A Holder may not use this Indenture to prejudice
the rights of another Holder or to obtain a preference or priority over another Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 6.07. <U>Rights of Holders To Receive
Payment</U>.</B> Notwithstanding any other provision of this Indenture, the right of any Holder of a Security to receive payment
of principal of or interest, if any, on the Security on or after the respective due dates expressed or provided for in the Security,
or to bring suit for the enforcement of any such payment on or after such respective dates, shall not be impaired or affected without
the consent of the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 6.08. <U>Collection Suit by Trustee</U>.</B>
If an Event of Default specified in <U>Section 6.01(i)</U> or <U>(ii)</U> occurs and is continuing with respect to Securities of
any series, the Trustee may recover judgment in its own name and as Trustee of an express trust against the Company for the whole
amount of principal (or such portion of the principal as may be specified as due upon acceleration at that time in the terms of
that series of Securities) and accrued interest, if any, remaining unpaid on the outstanding Securities of that series, together
with (to the extent lawful) interest on overdue principal and interest, and such further amount as shall be sufficient to cover
the costs and, to the extent lawful, expenses of collection, including the reasonable compensation, expenses, disbursements and
advances of the Trustee, its agents and counsel and any other amounts due the Trustee under <U>Section 7.07</U>.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 6.09. <U>Trustee May File Proofs
of Claim</U>.</B> The Trustee may file such proofs of claim and other papers or documents as may be necessary or advisable in order
to have the claims of the Trustee and the Holders allowed in any judicial proceeding relative to the Company (or any other obligor
upon the Securities), its creditors or its property and shall be entitled and empowered to participate as a member, voting or otherwise,
of any official committee of creditors appointed in such matter and to collect and receive any moneys or other property payable
or deliverable on any such claims and to distribute the same, and any custodian in any such judicial proceedings is hereby authorized
by each Holder to make such payments to the Trustee and, in the event that the Trustee shall consent to the making of such payments
directly to the Holders, to pay to the Trustee any amount due to it for the reasonable compensation, expenses, disbursements and
advances of the Trustee, its agents and counsel, and any other amounts due the Trustee under <U>Section 7.07</U>. Nothing herein
contained shall be deemed to authorize the Trustee to authorize or consent to or accept or adopt on behalf of any Holder any plan
of reorganization, arrangement, adjustment or composition affecting the Securities or the rights of any Holder thereof, or to authorize
the Trustee to vote in respect of the claim of any Holder in any such proceeding.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 6.10. <U>Priorities</U>.</B> If
the Trustee collects any money pursuant to this <U>Article VI</U>, it shall pay out the money in the following order:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">FIRST: to the Trustee, its
agents and attorneys for amounts due under <U>Section 7.07</U>, including payment of all compensation, expense and liabilities
incurred, and all advances made by the Trustee and the costs and expenses of collection;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">SECOND: to Holders of any particular
series of Securities for amounts due and unpaid on the Securities of such series for principal and interest, if any, ratably, without
preference or priority of any kind, according to the amounts due and payable on the Securities of such series for principal and
interest, respectively; and</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">THIRD: to the Company or any
other obligors on the Securities of that series, as their interests may appear, or as a court of competent jurisdiction may direct.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The Trustee, upon prior written notice to
the Company, may fix a record date and payment date for any payment to Holders pursuant to this Section 6.10. The Trustee shall
notify the Company in writing reasonably in advance of any such record date and payment date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 6.11. <U>Undertaking for Costs</U>.</B>
In any suit for the enforcement of any right or remedy under this Indenture or in any suit against the Trustee for any action taken
or omitted by it as a Trustee, a court in its discretion may require the filing by any party litigant in the suit of an undertaking
to pay the costs of the suit, and the court in its discretion may assess reasonable costs, including reasonable attorneys&rsquo;
fees and expenses, against any party litigant in the suit, having due regard to the merits and good faith of the claims or defenses
made by the party litigant. This <U>Section 6.11</U> does not apply to a suit by the Trustee, a suit by a Holder pursuant to <U>Section
6.07</U> or a suit by Holders of more than 10% in principal amount of the outstanding Securities of that series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE VII</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TRUSTEE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 7.01. <U>Duties of Trustee</U>.</B>
(a) If an Event of Default has occurred and is continuing, the Trustee shall exercise such of the rights and powers vested in it
by this Indenture, and use the same degree of care and skill in their exercise, as a prudent person would exercise or use under
the circumstances in the conduct of such person&rsquo;s own affairs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b)  Except
during the continuance of an Event of Default: (1) the Trustee need perform only those duties that are specifically set forth in
this Indenture or the TIA, and no implied covenants or obligations shall be read into this Indenture against the Trustee and (2)
in the absence of bad faith on its part, the Trustee may conclusively rely, as to the truth of the statements and the correctness
of the opinions expressed therein, upon certificates or opinions furnished to the Trustee and conforming to the requirements of
this Indenture. However, in the case of any such certificates or opinions which by any provision hereof are specifically required
to be furnished to the Trustee, the Trustee shall examine the certificates and opinions to determine whether or not, on their face,
they conform to the requirements of this Indenture.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(c)  The
Trustee may not be relieved from liability for its own negligent action, its own negligent failure to act or its own willful misconduct
except that: (1) this paragraph does not limit the effect of paragraph (b) of this <U>Section 7.01</U>, (2) the Trustee shall not
be liable for any error of judgment made in good faith by a Trust Officer or other officer, unless it is proved that the Trustee
was negligent in ascertaining the pertinent facts and (3) the Trustee shall not be liable with respect to any action it takes or
omits to take in good faith in accordance with a direction received by it pursuant to <U>Section 6.05</U>.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(d)  Whether
or not therein expressly so provided, every provision of this Indenture that in any way relates to the Trustee is subject to paragraphs
(a), (b), (c) and (e) of this <U>Section 7.01</U>.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(e)  No
provision of this Indenture shall require the Trustee to expend or risk its own funds or incur any liability. The Trustee may refuse
to perform any duty or exercise any right or power unless it receives indemnity satisfactory to it against any loss, liability,
cost or expense (including, without limitation, reasonable fees of counsel).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(f)  The
Trustee shall not be obligated to pay interest on any money or other assets received by it unless otherwise agreed in writing with
the Company. Assets held in trust by the Trustee need not be segregated from other funds except to the extent required by law.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 7.02. <U>Rights of Trustee</U>.
</B>Subject to <U>Section 7.01</U>:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)  The
Trustee may conclusively rely on any document (whether in its original or facsimile form) reasonably believed by it to be genuine
and to have been signed or presented by the proper person. The Trustee need not investigate any fact or matter stated in the document.
The Trustee shall receive and retain financial reports and statements of the Company as provided herein, but shall have no duty
to review or analyze such reports or statements to determine compliance under covenants or other obligations of the Company.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b)  Before
the Trustee acts or refrains from acting, it may require an Officers&rsquo; Certificate and/or an Opinion of Counsel. The Trustee
shall not be liable for any action it takes or omits to take in good faith in reliance on an Officers&rsquo; Certificate or Opinion
of Counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(c)  The
Trustee may act through its attorneys and agents and shall not be responsible for the misconduct or negligence of any agent appointed
with due care.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(d)  The
Trustee shall not be liable for any action it takes or omits to take in good faith which it believes to be authorized or within
its rights or powers, unless the Trustee&rsquo;s conduct constitutes willful misconduct or negligence.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(e)  The
Trustee may consult with counsel of its selection, and the advice or opinion of counsel with respect to legal matters relating
to this Indenture and the Securities shall be full and complete authorization and protection from liability in respect of any action
taken, omitted or suffered by it hereunder in good faith and in accordance with the advice or opinion of such counsel.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(f)  The
Trustee shall not be deemed to have notice of any Default or Event of Default unless a Trust Officer of the Trustee has actual
knowledge thereof or unless written notice of any event which is in fact such a default is received by the Trustee at the Corporate
Trust Office of the Trustee and such notice references the Securities and this Indenture.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(g)  The
rights, privileges, protections, immunities and benefits given to the Trustee, including, without limitation, its right to be indemnified,
are extended to, and shall be enforceable by, the Trustee in each of its capacities hereunder, and to each agent, custodian and
other Person employed to act hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(h)  The
Trustee shall be under no obligation to exercise any of the rights or powers vested in it by this Indenture at the request, order
or direction of any of the Holders pursuant to the provisions of this Indenture, unless such Holders shall have offered to the
Trustee reasonable security or indemnity against the costs, expenses and liabilities which may be incurred therein or thereby.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)  Whenever
in the administration of this Indenture the Trustee shall deem it desirable that a matter be proved or established prior to taking,
suffering or omitting any action hereunder, the Trustee (unless other evidence be herein specifically prescribed) may request,
and in the absence of bad faith or willful misconduct on its part, rely upon an Officers&rsquo; Certificate and an Opinion of Counsel.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(j)  The
Trustee may request that the Company deliver an Officers&rsquo; Certificate setting for the names of individuals and/or titles
of officers authorized at such times to take specified actions pursuant to this Indenture, which Officers&rsquo; Certificate may
be signed by any person specified as so authorized in any such certificate previously delivered and not superseded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 7.03. <U>Individual Rights of Trustee</U>.</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The Trustee in its individual or any other
capacity may become the owner or pledgee of Securities and may otherwise deal with the Company or an Affiliate of the Company with
the same rights it would have if it were not Trustee. Any Agent may do the same with like rights. However, the Trustee is subject
to <U>Sections 7.10</U> and <U>7.11</U>.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 7.04. <U>Trustee&rsquo;s Disclaimer</U>.</B>
The Trustee makes no representation as to the validity or adequacy of this Indenture or the Securities, it shall not be accountable
for the Company&rsquo;s use of the proceeds from the Securities and it shall not be responsible for any statement in the Securities
other than its certificate of authentication.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 7.05. <U>Notice of Defaults</U>.</B>
If a Default or Event of Default with respect to the Securities of any series occurs and is continuing, and if it is known to the
Trustee, the Trustee shall mail to Holders a notice of the Default or Event of Default within 90 days after the occurrence thereof.
Except in the case of a Default or Event of Default in payment of any such Security, the Trustee may withhold the notice if and
so long as it in good faith determines that withholding the notice is in the interests of the Holders.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 7.06. <U>Reports by Trustee to
Holders</U>.</B> The Trustee shall transmit to Holders such reports concerning the Trustee and its actions under this Indenture
as may be required by TIA Section 3.13 at the times and in the manner provided by the TIA, which shall initially be not less than
every twelve months commencing on and may be dated as of a date up to 75 days prior to such transmission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">A copy of each report at the time of its mailing
to Holders shall be filed with the SEC, if required, and each stock exchange, if any, on which the Securities are listed. The Company
shall promptly notify the Trustee when the Securities of any series are listed on any stock exchange.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 7.07. <U>Compensation and Indemnity</U>.</B>
The Company shall be liable for paying to the Trustee from time to time reasonable compensation for its acceptance of this Indenture
and services hereunder as the Company and the Trustee shall from time to time agree in writing. The Trustee&rsquo;s compensation
shall not be limited by any law on compensation of a trustee of an express trust. The Company shall be liable for reimbursing the
Trustee upon request for all reasonable out-of-pocket expenses incurred or made by it, including costs of collection, costs of
preparing and reviewing reports, certificates and other documents, costs of preparation and mailing of notices to Securityholders
and reasonable costs of counsel retained by the Trustee in connection with the delivery of an Opinion of Counsel or otherwise,
in addition to the compensation for its services. Such expenses shall include the reasonable compensation and expenses, disbursements
and advances of the Trustee&rsquo;s agents, counsel, accountants and experts. The Company shall indemnify the Trustee against any
and all loss, liability, damages, claims or expense (including reasonable attorneys&rsquo; fees and expenses) incurred by it without
negligence, bad faith or willful misconduct on its part in connection with the administration of this trust and the performance
of its duties hereunder, including the costs and expense of enforcing this Indenture (including this <U>Section 7.07</U>) and of
defending itself against any claims (whether asserted by any Securityholder, the Company or otherwise). Failure by the Trustee
to so notify the Company shall not relieve the Company of its obligations hereunder. The Company shall defend the claim, and the
Trustee shall provide reasonable cooperation at the Company&rsquo;s expense in the defense. The Trustee may have separate counsel
and the Company shall pay the fees and expenses of such counsel, <U>provided</U> that the Company shall not be required to pay
such fees and expenses if it assumes the Trustee&rsquo;s defense, and, in the reasonable judgment of outside counsel to the Trustee,
there is no conflict of interest between the Company and the Trustee in connection with such defense. Notwithstanding the foregoing,
the Company need not reimburse any expense or indemnify against any loss, liability or expense which is finally determined by a
court of competent jurisdiction to have been incurred by the Trustee through the Trustee&rsquo;s own willful misconduct, negligence
or bad faith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">To secure the Company&rsquo;s payment obligations
in this Section, the Trustee shall have a lien prior to the Securities on all money or property held or collected by the Trustee
other than money or property held in trust to pay principal of and interest on particular Securities. Such lien shall survive the
satisfaction and discharge of this Indenture. The Trustee&rsquo;s right to receive payment of any amounts due under this <U>Section
7.07</U> shall not be subordinate to any other liability or Indebtedness of the Company.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The Company&rsquo;s and the Subsidiary Guarantors&rsquo;
payment obligations pursuant to this Section shall survive the discharge of this Indenture. When the Trustee incurs expenses after
the occurrence of an Event of Default specified in clause (iv) or clause (v) of <U>Section 6.01</U> with respect to the Company,
the expenses are intended to constitute expenses of administration under any Bankruptcy Law.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 7.08. <U>Replacement of Trustee</U>.</B>
A resignation or removal of the Trustee and appointment of a successor Trustee shall become effective only upon the successor Trustee&rsquo;s
acceptance of appointment as provided in this <U>Section 7.08</U>.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The Trustee may resign and be discharged from
the trust hereby created with respect to one or more or all series of Securities by so notifying the Company in writing. The Holders
of a majority in principal amount of the then outstanding Securities of any series may remove the Trustee with respect to that
series by so notifying the Trustee and the Company in writing. The Company may remove the Trustee with respect to one or more or
all series of Securities if: (i) the Trustee fails to comply with <U>Section 7.10</U> or TIA Section 310; (ii) the Trustee is adjudged
a bankrupt or an insolvent or an order for relief is entered with respect to the Trustee under any Bankruptcy Law; (iii) a Custodian
or public officer takes charge of the Trustee or its property; or (iv) the Trustee becomes incapable of acting.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">If, as to any series of Securities, the Trustee
resigns or is removed or if a vacancy exists in the office of the Trustee for any reason, the Company shall promptly appoint a
successor Trustee for that series of Securities. The Trustee shall be entitled to payment of its fees and reimbursement of its
expenses while acting as Trustee. Within one year after the successor Trustee takes office, the Holders of at least a majority
in principal amount of then outstanding Securities of that series may appoint a successor Trustee to replace the successor Trustee
appointed by the Company.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">Any Holder of Securities of that series may
petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor Trustee if the Trustee
fails to comply with <U>Section 7.10</U>.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">A successor Trustee as to any series of Securities
shall deliver a written acceptance of its appointment to the retiring Trustee and to the Company. Thereupon the resignation or
removal of the retiring Trustee shall become effective, and the successor Trustee shall have all the rights, powers and duties
of the Trustee under this Indenture. The Company shall mail a notice of the successor Trustee&rsquo;s succession to the Holders.
The retiring Trustee shall promptly transfer all property held by it as Trustee to the successor Trustee, subject to the lien provided
for in <U>Section 7.07</U>. Notwithstanding replacement of the Trustee pursuant to this <U>Section 7.08</U>, the Company&rsquo;s
obligations under <U>Section 7.07</U> hereof shall continue for the benefit of the retiring Trustee with respect to expenses, losses
and liabilities incurred by it prior to such replacement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">In case of the appointment hereunder of a
successor Trustee with respect to the Securities of one or more (but not all) series, the Company, the retiring Trustee and each
successor Trustee with respect to the Securities of one or more series shall execute and deliver an indenture supplemental hereto
wherein each successor Trustee shall accept such appointment and which (1) shall contain such provisions as shall be necessary
or desirable to transfer and confirm to, and to vest in, each successor Trustee all the rights, powers, trusts and duties of the
retiring Trustee with respect to the Securities of that or those series to which the appointment of such successor Trustee relates,
(2) shall contain such provisions as shall be necessary or desirable to confirm that all the rights, powers, trusts and duties
of the retiring Trustee with respect to the Securities of that or those series as to which the retiring Trustee is not retiring
shall continue to be vested in the retiring Trustee, and (3) shall add to or change any of the provisions of this Indenture as
shall be necessary or desirable to provide for or facilitate the administration of the trusts hereunder by more than one Trustee;
<U>provided</U>, <U>however</U>, that nothing herein or in such supplemental indenture shall constitute such Trustees to be co-Trustees
of the same trust and that each such Trustee shall be Trustee of a trust hereunder separate and apart from any trust hereunder
administered by any other such Trustee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">Upon the execution and delivery of such supplemental
indenture the resignation or removal of the retiring Trustee shall become effective to the extent provided therein and each such
successor Trustee, without any further act, deed or conveyance, shall become vested with all the rights, powers, trusts and duties
of the retiring Trustee with respect to the Securities of that or those series to which the appointment of such successor Trustee
relates.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 7.09. <U>Successor Trustee by Merger,
Etc</U>. </B> Subject to Section 7.10, if the Trustee consolidates with, merges or converts into, or transfers all or substantially
all of its corporate trust business to, another corporation or national banking association, the successor entity without any further
act shall be the successor Trustee as to that series of Securities.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 7.10. <U>Eligibility; Disqualification</U>.</B>
Each series of Securities shall always have a Trustee who satisfies the requirements of TIA Section 310(a) (1), (2) and (5). The
Trustee as to any series of Securities shall always have a combined capital and surplus of at least $100 million as set forth in
its most recent published annual report of condition. The Trustee is subject to TIA Section 310(b).</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 7.11. <U>Preferential Collection
of Claims Against the Company</U>.</B> The Trustee is subject to TIA Section 311(a), excluding any creditor relationship listed
in TIA Section 311 (b). A Trustee who has resigned or been removed shall be subject to TIA Section 311(a) to the extent indicated
therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE VIII<BR>
<BR>
DISCHARGE OF INDENTURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 8.01. <U>Satisfaction and Discharge
of Indenture</U>.</B> This Indenture shall cease to be of further effect (except as to any surviving rights of registration of
transfer or exchange of Securities herein expressly provided for), and the Trustee, at the expense of the Company, shall execute
proper instruments acknowledging satisfaction and discharge of this Indenture, when</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a) either</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">(i) all Securities
theretofore authenticated and delivered (other than Securities that have been destroyed, lost or stolen and that have been replaced
or paid) have been delivered to the Trustee for cancellation; or</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">(ii) all such
Securities not theretofore delivered to the Trustee for cancellation</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">(1) have
become due and payable, or</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">(2) will
become due and payable at their stated maturity within one year, or</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">(3) are to
be called for redemption within one year under arrangements satisfactory to the Trustee for the giving of notice of redemption
by the Trustee in the name, and at the expense, of the Company, or</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">(4) are deemed
paid and discharged pursuant to Section 8.03, as applicable;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">and the Company, in the case of (1), (2) or (3) above,
has deposited or caused to be deposited with the Trustee as trust funds in trust an amount sufficient for the purpose of paying
and discharging the entire indebtedness on such Securities not theretofore delivered to the Trustee for cancellation, for principal
and interest to the date of such deposit (in the case of Securities which have become due and payable on or prior to the date of
such deposit) or to the stated maturity or redemption date, as the case may be;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b) the
Company has paid or caused to be paid all other sums payable hereunder by the Company; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(c) the
Company has delivered to the Trustee an Officers&rsquo; Certificate and an Opinion of Counsel, each stating that all conditions
precedent herein provided for relating to the satisfaction and discharge of this Indenture have been complied with.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">Notwithstanding the satisfaction and discharge
of this Indenture, the obligations of the Company to the Trustee under <U>Section 7.07</U>, and, if money shall have been deposited
with the Trustee pursuant to clause (a) of this Section or if money or obligations shall have been deposited with or received by
the Trustee pursuant to <U>Section 8.03</U>, the obligations of the Trustee under <U>Section 8.02</U> and <U>Section 8.05</U> shall
survive.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 8.02. <U>Application of Trust Funds;
Indemnification</U>.</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a) Subject
to the provisions of <U>Section 8.05</U>, all money deposited with the Trustee pursuant to <U>Section 8.01</U>, all money and U.S.
Government Obligations deposited with the Trustee pursuant to <U>Section 8.03</U> or <U>8.04</U> and all money received by the
Trustee in respect of U.S. Government Obligations deposited with the Trustee pursuant to <U>Section 8.03</U> or <U>8.04</U>, shall
be held in trust and applied by it, in accordance with the provisions of the Securities and this Indenture, to the payment, either
directly or through any Paying Agent (including the Company acting as its own Paying Agent) as the Trustee may determine, to the
persons entitled thereto, of the principal and interest for whose payment such money has been deposited with or received by the
Trustee or to make mandatory sinking fund payments or analogous payments as contemplated by <U>Sections 8.03</U> and <U>8.04</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b) The
Company shall pay and shall indemnify the Trustee against any tax, fee or other charge imposed on or assessed against U.S. Government
Obligations deposited pursuant to <U>Sections 8.03</U> or <U>8.04</U> or the interest and principal received in respect of such
obligations other than any payable by or on behalf of Holders.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(c) The
Trustee shall deliver or pay to the Company from time to time upon the request of the Company any U.S. Government Obligations or
money held by it as provided in <U>Sections 8.03</U> or <U>8.04</U> which, in the opinion of a nationally recognized firm of independent
certified public accountants expressed in a written certification thereof delivered to the Trustee, are then in excess of the amount
thereof which then would have been required to be deposited for the purpose for which such U.S. Government Obligations or money
were deposited or received. This provision shall not authorize the sale by the Trustee of any U.S. Government Obligations held
under this Indenture.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 8.03. <U>Legal Defeasance of Securities
of any Series</U>.</B> Unless this <U>Section 8.03</U> is otherwise specified to be inapplicable to Securities of any series, the
Company shall be deemed to have paid and discharged the entire indebtedness on all the outstanding Securities of any such series
on the 91st day after the date of the deposit referred to in subparagraph (a) hereof, and the provisions of this Indenture, as
it relates to such outstanding Securities of such series, shall no longer be in effect (and the Trustee, at the expense of the
Company, shall, upon the request of the Company, execute proper instruments acknowledging the same), except as to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i) the
rights of Holders of Securities of such series to receive, from the trust funds described in subparagraph (d) hereof, (x) payment
of the principal of an each installment of principal of or interest on the outstanding Securities of such series on the stated
maturity of such principal of or interest and (y) the benefit of any mandatory sinking fund payments applicable to the Securities
of such series on the day on which such payments are due and payable in accordance with the terms of this Indenture and the Securities
of such series;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii) the
Company&rsquo;s obligations with respect to such Securities of such series under <U>Sections 2.03</U>, <U>2.06</U> and <U>2.07</U>;
and</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iii) the
rights, powers, trust and immunities of the Trustee hereunder and the duties of the Trustee under <U>Section 8.02</U> and the duty
of the Trustee to authenticate Securities of such series issued on registration of transfer of exchange;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">provided that, the following conditions shall
have been satisfied:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a) the
Company shall have deposited or caused to be deposited irrevocably with the Trustee as trust funds in trust for the purpose of
making the following payments, specifically pledged as Security for and dedicated solely to the benefit of the Holders of such
Securities, cash in U.S. Dollars and/or U.S. Government Obligations which through the payment of interest and principal in respect
thereof, in accordance with their terms, will provide (and without reinvestment and assuming no tax liability will be imposed on
such Trustee), not later than one day before the due date of any payment of money, an amount in cash, sufficient, in the opinion
of a nationally recognized firm of independent public accountants expressed in a written certification thereof delivered to the
Trustee, to pay and discharge each installment of principal (including mandatory sinking fund or analogous payments) of and interest,
if any, on all the Securities of such series on the dates such installments of interest or principal are due;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b) such
deposit will not result in a breach or violation of, or constitute a default under, this Indenture;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(c) no
Default or Event of Default with respect to the Securities of such series shall have occurred on the date of such deposit and 91
days shall have passed after the deposit has been made, and, during such 91 day period, no Default specified in Section 6.0l(iv)
or (v) with respect to the Company occurs which is continuing at the end of such period;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(d) the
Company shall have delivered to the Trustee an Officers&rsquo; Certificate and an Opinion of Counsel to the effect that (i) the
Company has received from, or there has been published by, the Internal Revenue Service a ruling, or (ii) since the date of execution
of this Indenture, there has been a change in the applicable Federal income tax law, in either case to the effect that, and based
thereon such Opinion of Counsel shall confirm that, the Holders of the Securities of such series will not recognize income, gain
or loss for Federal income tax purposes as a result of such deposit, defeasance and discharge and will be subject to Federal income
tax on the same amount and in the same manner and at the same times as would have been the case if such deposit, defeasance and
discharge had not occurred;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(e) the
Company shall have delivered to the Trustee an Officers&rsquo; Certificate stating that the deposit was not made by the Company
with the intent of preferring the Holders of the Securities of such series over any other creditors of the Company or with the
intent of defeating, hindering, delaying or defrauding any other creditors of the Company;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(f) such
deposit shall not result in the trust arising from such deposit constituting an investment company (as defined in the Investment
Company Act of 1940, as amended), or such trust shall be qualified under such Act or exempt from regulation thereunder; and</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(g) the
Company shall have delivered to the Trustee an Officers&rsquo; Certificate and an Opinion of Counsel, each stating that all conditions
precedent relating to the defeasance contemplated by this Section have been complied with.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 8.04. <U>Covenant Defeasance</U>.</B>
Unless this <U>Section 8.04</U> is otherwise inapplicable to Securities of any series, on and after the 91st day after the date
of the deposit referred to in subparagraph (a) hereof, the Company may omit to comply with any term, provision or condition set
forth under <U>Sections 4.03</U>, <U>4.04</U> and <U>4.05</U> as well as any additional covenants contained in a supplemental indenture
hereto for a particular series of Securities or a Board Resolution or an Officers&rsquo; Certificate delivered pursuant to <U>Section
2.01</U> (and the failure to comply with any such provisions shall not constitute a Default or Event of Default under <U>Section
6.01</U>) and the occurrence of any event described in clause (e) of <U>Section 6.01</U> shall not constitute a Default or Event
of Default hereunder, with respect to the Securities of such series, provided that the following conditions shall have been satisfied:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a) With
reference to this <U>Section 8.04</U>, the Company has deposited or caused to be irrevocably deposited (except as provided in <U>Section
8.03</U>) with the Trustee as trust funds in trust, specifically pledged as Security for, and dedicated solely to, the benefit
of the Holders of such Securities, cash in U.S. Dollars and/or U.S. Government Obligations which through the payment of interest
and principal in respect thereof, in accordance with their terms, will provide (and without reinvestment and assuming no tax liability
will be imposed on such Trustee), not later than one day before the due date of any payment of money, an amount in cash, sufficient,
in the opinion of a nationally recognized firm of independent certified public accountants expressed in a written certification
thereof delivered to the Trustee, to pay principal and interest, if any, on and any mandatory sinking fund in respect of the Securities
of such series on the dates such installments of interest or principal are due;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b) Such
deposit will not result in a breach or violation of, or constitute a default under, this Indenture;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(c) No
Default or Event of Default with respect to the Securities of such series shall have occurred on the date of such deposit and 91
days shall have passed after the deposit has been made, and, during such 91 day period, no Default specified in Section 6.01(iv)
or (v) with respect to the Company occurs which is continuing at the end of such period;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(d) The
Company shall have delivered to the Trustee an Opinion of Counsel confirming that Holders of the Securities of such series will
not recognize income, gain or loss for federal income tax purposes as a result of such deposit and defeasance and will be subject
to federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such deposit
and defeasance had not Occurred;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(e) The
Company shall have delivered to the Trustee an Officers&rsquo; Certificate stating the deposit was not made by the Company with
the intent of preferring the Holders of the Securities of such series over any other creditors of the Company or with the intent
of defeating, hindering, delaying or defrauding any other creditors of the Company; and</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(f) The
Company shall have delivered to the Trustee an Officers&rsquo; Certificate and an Opinion of Counsel, each stating that all conditions
precedent herein provided for relating to the defeasance contemplated by this Section have been complied with.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 8.05. <U>Repayment to Company</U>.</B>
The Trustee and the Paying Agent shall pay to the Company upon request any money held by them for the payment of principal or interest
that remains unclaimed for two years after the date upon which such payment shall have become due. After payment to the Company,
Holders entitled to the money must look to the Company for payment as general creditors unless an applicable abandoned property
law designates another Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE IX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDMENTS, SUPPLEMENTS AND WAIVERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 9.01. <U>Without Consent of Holders</U>.</B>
The Company and the Trustee may amend this Indenture or the Securities without the consent of any Holder: (i) to cure any ambiguity,
defect or inconsistency or make any change required to qualify the indenture under the TIA, provided that such change does not
adversely affect the rights hereunder of any Holder in any material respect; (ii) to comply with <U>Section 5.01</U>; (iii) to
provide for uncertificated Securities in addition to certificated Securities; (iv) to make any change that does not adversely affect
in any material respect the rights hereunder of any Holder; (v) to add to, change or eliminate any of the provisions of this Indenture
in respect of one or more series of Securities, <U>provided</U>, <U>however</U>, that any such addition, change or elimination
(A) shall neither (i) apply to any Security of any series created prior to the execution of such supplemental indenture and entitled
to the benefit of such provision nor (ii) modify the rights of the holder of any such Security with respect to such provision or
(B) shall become effective only when there is no outstanding Security of any series created prior to the execution of such supplemental
indenture and entitled to the benefit of such provisions; or (vi) to establish additional series of Securities as permitted by
<U>Section 2.01</U>.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 9.02. <U>With Consent of Holders</U>.</B>
The Company and the Trustee as to any series of Securities may amend this Indenture or the Securities of that series or waive compliance
in any particular instance with any provision of this Indenture or the Securities of that series, in each case with the written
consent of the Holders of at least a majority in principal amount of the then outstanding Securities of that series.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">Without the consent of each Holder affected,
an amendment or waiver under this Section may not: (i) reduce the principal amount of Securities, whose Holders must consent to
an amendment or waiver; (ii) reduce the rate of or change the time for payment of interest on any Security; (iii) change the date
on which any Security may be subject to redemption or repurchase, or reduce the redemption or repurchase price therefor; (iv) make
any Security payable in currency other than that stated in the Security; or (v) make any change in <U>Section 6.04</U>, <U>6.07</U>
or this sentence.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">It shall not be necessary for the consent
of the Holders under this Section to approve the particular form of any proposed amendment or waiver, but it shall be sufficient
if such consent approves the substance thereof.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">An amendment or waiver under this Section
which waives, changes or eliminates any covenant or other provision of this Indenture which has expressly been included solely
for the benefit of one or more particular series of Securities, or which modifies the rights of the Holders of Securities of such
series with respect to such covenant or other provision, shall be deemed not to affect the rights under this Indenture of the Holders
of Securities of any other series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The Company will mail supplemental indentures
to Holders upon request. Any failure of the Company to mail such notice, or any defect therein, shall not, however, in any way
impair or affect the validity of any such supplemental indenture or waiver.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 9.03. <U>Compliance with Trust
Indenture Act</U>.</B> Every amendment to this Indenture or the Securities shall be set forth in a supplemental indenture that
complies with the TIA as then in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 9.04. <U>Revocation and Effect
of Consents</U>. </B>Until an amendment or waiver becomes effective, a consent to it by a Holder of a Security is a continuing
consent by the Holder and every subsequent Holder of a Security or portion of a Security that evidences the same debt as the consenting
Holder&rsquo;s Security, even if notation of the consent is not made on any Security; <U>provided</U>, <U>however</U>, that unless
a record date shall have been established pursuant to <U>Section 2.14</U>, any such Holder or subsequent Holder may revoke the
consent as to his Security or portion of a Security if the Trustee receives written notice of revocation before the date the amendment
or waiver becomes effective. An amendment or waiver becomes effective on receipt by the Trustee of consents from the Holders of
the requisite percentage principal amount of the outstanding Securities of any series, and thereafter shall bind every Holder of
Securities of that series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 9.05. <U>Notation on or Exchange
of Securities</U>.</B> If an amendment or waiver changes the terms of a Security: (a) the Trustee may require the Holder of the
Security to deliver such Security to the Trustee, the Trustee may place an appropriate notation on the Security about the changed
terms and return it to the Holder and the Trustee may place an appropriate notation on any Security thereafter authenticated; or
(b) if the Company or the Trustee so determines, the Company in exchange for the Security shall issue and the Trustee shall authenticate
a new Security that reflects the changed terms.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 9.06. <U>Trustee to Sign Amendment,
etc</U>.</B> The Trustee shall sign any amendment authorized pursuant to this <U>Article IX</U> if the amendment does not adversely
affect the rights, duties, liabilities or immunities of the Trustee. If it does, the Trustee may, but need not sign it. In signing
or refusing to sign such amendment, the Trustee shall be entitled to receive and shall be fully protected in relying upon an Officers&rsquo;
Certificate and an Opinion of Counsel as conclusive evidence that such amendment is authorized or permitted by this Indenture and
that such amendment, supplement or waiver is the legal, valid and binding obligation of the Company, enforceable against it in
accordance with its terms, subject to customary exceptions, and complies with the provisions hereof (including <U>Section 9.03</U>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE X<BR>
<BR>
MISCELLANEOUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 10.01. <U>Trust Indenture Act Controls</U>.</B>
This Indenture is subject to the provisions of the TIA which are required to be part of this Indenture, and shall, to the extent
applicable, be governed by such provisions.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 10.02. <U>Notices</U>. </B> Any
notice or communication to the Company or the Trustee is duly given if in writing and delivered in person or mailed by first-class
mail to the address set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 1in; font-size: 10pt"><FONT STYLE="font-size: 10pt">China Pharma Holdings, Inc.&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 1in; font-size: 10pt"><FONT STYLE="font-size: 10pt"><U>Second Floor, No. 17, Jinpan Road</U>,</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 1in; font-size: 10pt"><FONT STYLE="font-size: 10pt"><U>Haikou, Hainan Province, </U></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 1in; font-size: 10pt"><FONT STYLE="font-size: 10pt">People&rsquo;s Republic of China <U>570216</U></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attn: Zhilin Li</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">+86 898-6681-1730</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">with a copy to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Pryor Cashman LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">7 Times Square</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">New York, New York 10036</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attention: Elizabeth F. Chen, Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">If to the Trustee:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">[____________________]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">_____________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">_____________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">_____________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attention: ____________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">With a copy to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">_____________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">_____________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">_____________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">Attention: ____________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The Company or the Trustee by notice to the
other may designate additional or different addresses for subsequent notices or communications.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">Any notice or communication to a Holder shall
be mailed by first-class mail to his address shown on the register kept by the registrar. Failure to mail a notice or communication
to a Holder or any defect in such notice or communication shall not affect its sufficiency with respect to other Holders.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">If a notice or communication is mailed or
sent in the manner provided above within the time prescribed, it is duly given, whether or not the addressee receives it, except
that notice to the Trustee shall only be effective upon receipt thereof by the Trustee.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">If the Company mails a notice or communication
to Holders, it shall mail a copy to the Trustee and each Agent at the same time.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 10.03. <U>Communication by Holders
with Other Holders</U>. </B> Holders may communicate pursuant to TIA Section 312(b) with other Holders with respect to their rights
under this Indenture or the Securities. The Company, the Trustee, the registrar and anyone else shall have the protection of TIA
Section 312 (c)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 10.04. <U>Certificate and Opinion
as to Conditions Precedent</U>.</B> Upon any request or application by the Company to the Trustee to take any action under this
Indenture, the Company shall furnish to the Trustee: (1) an Officers&rsquo; Certificate (which shall include the statements set
forth in Section 10.05) stating that, in the opinion of the signers, all conditions precedent and covenants, if any, provided for
in this Indenture relating to the proposed action have been complied with; and (ii) an Opinion of Counsel (which shall include
the statements set forth in Section 10.05) stating that, in the opinion of such counsel, all such conditions precedent and covenants
have been complied with.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 10.05. <U>Statements Required in
Certificate or Opinion</U>.</B> Each certificate (other than certificates provided pursuant to <U>Section 4.04</U>) or opinion
with respect to compliance with a condition or covenant provided for in this Indenture shall include: (i) a statement that the
person making such certificate or opinion has read such covenant or condition; (ii) a brief statement as to the nature and scope
of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are based; (iii)
a statement that, in the opinion of such person, he or she has made such examination or investigation as is necessary to enable
him to express an informed opinion as to whether or not such covenant or condition has been complied with; and (iv) a statement
as to whether or not, in the opinion of such person, such condition or covenant has been complied with; <U>provided</U>, <U>however</U>,
that with respect to matters of fact, an Opinion of Counsel may rely on an Officers&rsquo; Certificate or certificate of public
officials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 10.06. <U>Rules by Trustee and
Agents</U>.</B> The Trustee may make reasonable rules for action by or for a meeting of Holders. The Registrar or Paying Agent
may make reasonable rules and set reasonable requirements for its functions.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 10.07. <U>Legal Holidays</U>.</B>
A &ldquo;<U>Legal Holiday</U>&rdquo; is a Saturday, a Sunday or a day on which banking institutions in the City of New York are
not required or authorized to be open. If a payment date is a Legal Holiday at a place of payment, payment may be made at that
place on the next succeeding day that is not a Legal Holiday, and no interest shall accrue for the intervening period.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 10.08. <U>Duplicate Originals</U>.</B>
The parties may sign any number of copies of this Indenture. One signed copy is enough to prove this Indenture.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 10.09. <U>Governing Law</U>.</B>
The internal laws of the State of [___________] shall govern this Indenture and the Securities, without regard to the conflicts
of Law rules thereof.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 10.10. <U>No Adverse Interpretation
of Other Agreements</U>.</B> This Indenture may not be used to interpret another indenture, loan or debt agreement of the Company
or any subsidiary. Any such indenture, loan or debt agreement may not be used to interpret this Indenture.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 10.11. <U>Successors</U>.</B> All
agreements of the Company in this Indenture and the Securities shall bind their respective successors. All agreements of the Trustee
in this Indenture shall bind its successor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 10.12. <U>Severability</U>.</B>
In case any provision in this Indenture or in the Securities shall be invalid, illegal or unenforceable, the validity, legality
and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>SECTION 10.13. <U>Counterpart Originals</U>.
</B> This Indenture may be signed in one or more counterparts. Each signed copy shall be an original, but all of them together
represent the same agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">China
Pharma Holdings, Inc.&nbsp;</P>

</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 35%">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Dated:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify"><U>[ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</U></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Dated:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">24</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>ea132953ex5-1_chinapharma.htm
<DESCRIPTION>OPINION OF FLANGAS LAW GROUP AS TO THE LEGALITY OF THE SECURITIES BEING REGISTERED
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
5.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt; font-variant: small-caps"><I><SUP>FLG
</SUP></I><B>Flangas Law Group</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Writer&rsquo;s
email: kps@fdlawlv.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
8, 2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board
of Directors</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">China
Pharma Holdings, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second
Floor, No. 17, Jinpan Road</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Haikou,
Hainan Province, China 570216&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 53px; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Re:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 7px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">China
                                         Pharma Holdings, Inc.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration
        Statement on Form S-3</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
your requests, we have acted as special Nevada counsel to China Pharma Holdings, Inc., a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;),
and have examined the Registration Statement on Form S-3 (as it may be amended from time to time, the &ldquo;<U>Registration Statement</U>&rdquo;)
to be filed with the Securities and Exchange Commission by the Company, under the Securities Act of 1933, as amended, with respect
to the registration of up to $50,000,000 of any combination of (i) common stock, par value $0.001 per share (the &ldquo;<U>Common
Stock</U>&rdquo;), of the Company, (ii) preferred stock, par value $0.001 per share, of the Company (the &ldquo;<U>Preferred Stock</U>&rdquo;),
(iii) debt securities of the Company (the &ldquo;<U>Debt Securities</U>&rdquo;), (iv) warrants to purchase Common Stock, Preferred
Stock, Debt Securities or Units (as defined below) (&ldquo;<U>Warrants</U>&rdquo;), (v) units comprised of Common Stock, Preferred
Stock, Debt Securities and Warrants in any combination (&rdquo;<U>Units</U>&rdquo;) or (vi) rights to purchase shares of Common
Stock or Preferred Stock (&rdquo;<U>Rights</U>&rdquo;). The Common Stock, Preferred Stock, Warrants, Debt Securities, Units and
Rights are sometimes referred to collectively herein as the &ldquo;<U>Securities</U>.&rdquo; Securities may be issued in an unspecified
number (with respect to Common Stock, Preferred Stock, Warrants, Units and Rights) or in an unspecified principal amount (with
respect to Debt Securities). The Registration Statement provides that the Securities may be offered separately or together, in
separate series, in amounts, at prices and on terms to be set forth in one or more prospectus supplements (each a &ldquo;<U>Prospectus
Supplement</U>&rdquo;) to the prospectus contained in the Registration Statement. We are providing this letter to express our
opinion on the matters set forth in the numbered paragraphs below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
opinion is furnished to the Company in regards to the Registration Statement. Capitalized terms used herein and not otherwise
defined herein shall have the meanings given to such terms in the Registration Statement. In rendering this opinion, we have examined
such matters of fact as we have deemed necessary in order to render the opinions set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
render this opinion only with respect to, and we express no opinion herein concerning the application or effect of the laws of
any jurisdiction other than, the existing laws of the state of Nevada. We express no opinion with respect to any other laws or
with respect to the &ldquo;blue sky&rdquo; securities laws of any state.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3275
South Jones Blvd., Suite 105 | Las Vegas, Nevada 89146 | Phone: (702) 307-9500 | Fax: (702) 382-9452</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
8, 2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
2 of 3</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
our examination of documents for purposes of this opinion, we have relied on the accuracy of representations to us by officers
of the Company with respect to all signatures, the authenticity of all documents submitted to us as originals, the conformity
to original documents of all documents submitted to us as reproduced or certified copies, and the authenticity of the originals
of those latter documents. As to questions of fact material to this opinion, we have, to the extent deemed appropriate, relied
upon certain representations of certain officers of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent our opinion set forth in Paragraph 1 below is dependent on the existence and good standing under the laws of the State
of Nevada, we have relied exclusively on the Good Standing Certificate dated December 17, 2020. In connection with our opinion
expressed in paragraph 2 below, we have assumed that, at or prior to the time of the delivery of any Securities, the Registration
Statement will have been declared effective under the Securities Act of 1933, as amended (the &ldquo;<U>Act</U>&rdquo;), the registration
will apply to all the Securities to be issued, and will not have been modified or rescinded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of the opinions set forth below, we refer to the following as the &ldquo;Future Authorization and Issuance&rdquo; of
Securities:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
    respect to any of the Securities, (a)&nbsp;the authorization by the Company of the amount, terms and issuance of such Securities
    (the &ldquo;<U>Authorization</U>&rdquo;), and (b)&nbsp;the issuance of such Securities in accordance with the Authorization
    therefor upon the receipt by the Company of the consideration (which, in the case of shares of Common Stock or Preferred Stock,
    is not less than the par value of such shares) to be paid therefor in accordance with the Authorization;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
    respect to Warrants, Debt Securities, Units or Rights, (a)&nbsp;the authorization, execution and delivery by the Company and
    the other parties thereto of any agreement under which such Securities are to be issued and (b)&nbsp;the establishment of
    the terms of such Securities, and the execution and delivery of such Securities, in conformity with any applicable agreement
    under which such Securities are to be issued and applicable law.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
upon the foregoing and subject to the assumptions, exceptions, limitations and qualifications set forth herein, we are of the
opinion that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company is a corporation validly existing and in good standing under the laws of the
                                         state of Nevada.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                         the Future Authorization and Issuance of shares of Common Stock, such shares of Common
                                         Stock will be validly issued, fully paid and nonassessable.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
8, 2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
3 of 3</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                         the Future Authorization and Issuance of shares of Preferred Stock, such shares of Preferred
                                         Stock will be validly issued, fully paid and nonassessable.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                         the Future Authorization and Issuance of Warrants, such Warrants will be valid and binding
                                         obligations of the Company, enforceable against the Company in accordance with their
                                         terms.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                         the Future Authorization and Issuance of Debt Securities, such Debt Securities will be
                                         valid and binding obligations of the Company, enforceable against the Company in accordance
                                         with their terms.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                         the Future Authorization and Issuance of Units, such Units will be valid and binding
                                         obligations of the Company, enforceable against the Company in accordance with their
                                         terms.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                         the Future Authorization and Issuance of Rights, such Rights will be valid and binding
                                         obligations of the Company, enforceable against the Company in accordance with their
                                         terms.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the filing of this opinion as Exhibit 5.1 to the Registration Statement and to the reference to our firm in
the prospectus contained in the Registration Statement. In giving the foregoing consent, we do not admit that we are in the category
of persons whose consent is required under Section 7 of the Act, or the rules and regulations of the Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
opinion is rendered pursuant to Item 601(b)(5) of Regulation S-K under the Securities Act and may not be used, circulated, quoted
or relied upon for any other purpose. This opinion is rendered on, as speaks only as of, the date of this letter first written
above, is based solely on our understanding of facts in existence as of such date and does not address any potential changes in
facts or circumstance that may occur after the date of this opinion letter. We assume no obligation to advise you of any fact,
circumstance, event or change in the law or the facts that may hereafter be brought to our attention whether or not such occurrence
would affect or modify any of the opinions expressed herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%">Very truly yours,</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font-variant: small-caps">/s/ FLANGAS LAW GROUP</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font-weight: bold">FLANGAS LAW GROUP</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>4
<FILENAME>ea132953ex23-2_chinapharma.htm
<DESCRIPTION>CONSENT OF BF BORGERS CPA, P.C., AN INDEPENDENT REGISTERED ACCOUNTING FIRM
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 23.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><IMG SRC="ex23-2_01.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">We hereby
consent to the incorporation by reference in this Registration Statement on Form S-3 of our report dated March 30, 2020, relating
to the consolidated balance sheets of China Pharma Holdings, Inc. as of December 31, 2019 and 2018, the related consolidated statements
of operations and comprehensive income (loss), stockholders&rsquo; equity, and cash flows for each of the two years in the period
ended December 31, 2019, and the related notes, to the reference to our firm </FONT>under the caption &ldquo;Experts&rdquo; <FONT STYLE="font-size: 10pt">in
this Registration Statement filed with the U.S. Securities and Exchange Commission on January 8, 2021. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>/S/ B F Borgers CPA PC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Lakewood, Colorado</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">January 8, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  Y 2H# 2(  A$! Q$!_\0
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ME474M+N+74+:"=TM;F.WNU1H+R&XMY)(F\J_X(@7-S=?\$M?V1Y+JYN+J1?
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M"YEFDJ\:^6Y5_:.*C/$99+"8FEBZE*ACY5J<:/LW_+M^Q+_P44_;._9:\/\
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M&+_^W?'>MZBO]I6EG;:$M^;'0-)L;&WFL;C5=*O6O);FY@G-EM0BON3]LO\
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M4]0N_ &O06=AIUC;))<7E]=SR1P6MK CS3S2)%&K.P!^6?\ @C!X4\4>"/\
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M7U)/-244 4+C3+*ZGCN9X$DEC#!&95.-VW)P0>1M7![8%7P   .@&!]!110
*4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $3 2P# 2(  A$! Q$!_\0
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MS#S_ /)O\C^C[_B)B_;]_P">?P9_\-WI_P#\L*/^(F+]OW_GG\&?_#=Z?_\
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M-\ 6>/M?@W5K36K_ /L[PO>\'_3_  Z#VY&.?S._;2^-7P]_:._:H^)WQO\
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M?$CP5#\,_@OX0^&%U9^+-9M9_#FO#PA;&T^U?V397W''!_M'KV'I];?LV_\
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M/!GQ<UOQ)^S7^U5IW[4$NOZ'=>#;?2M2.CYO+33/]-ON/[.L2-.'IUYS7?\
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M[^P^%_PJ\'_%_P 6^,/"_B/5/$?AS3?"_CS5/L?AZU_T+0SJ'V[4; VFH?\
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MQ-NW]E7@&.E?HW^T!IO@*;]CG]L#PEKWC_X#^)_&&H?"#]F#QOX7_P"$;NO
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M4W-Q_P ^=Q_WZ%)BZ_Y\Y_R%'UC"?]!*_P#)?\SE^KU?Y7]S_P A]%-S<?\
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M?$C_ ,./K_\ A7[YIT/U_H*?7H4<]SU4U?&337GMTZIO\3SO[$RO_H%7W(_
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MO^A0^)'_ (<?7_\ "C_B&V_X)G?]"A\2/_#CZ_\ X5^^U%5_;N>_]!E3^O\
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M^A0^)'_AQ]?_ ,*/^(;;_@F=_P!"A\2/_#CZ_P#X5^^U%']NY[_T%U/O_P"
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M17BG_#0OP1_Z*_\ #;_PK=(_^6%)_P -"_!3_HKGPW_\*W2/_EA71_9^>_\
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M3_Y /[1R_P#Z"(_>O\SVFF.2=V>T1'X<UXS_ ,-!_!3_ **]\-/_  LM _\
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M=:%:78Y ;0[IM/!Z$@\ YKF_$'["?[*_CWPM\,?!FN_!_P )Z]X/^$_AR_\
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M_17/AO\ ^%;I'_RPI?\ AH7X(_\ 17_AM_X5ND?_ "PH_L_/?^@27_@NK_\
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MGV]?D)_PO'XG?]!O_P BZI_\G4?\+Q^)W_0;_P#(NJ?_ "=7D<?[SS=CQO\
M9^H$O^?PY_ER5W_5<)_T#+_P&/\ \B8O%5^[_P# G_F>N?\ "\?B=_T&_P#R
M+JG_ ,G4?\+Q^)W_ $&__(NJ?_)U>1T4OJN$_P"@9?\ @,?_ )$\YYABM?\
M:5U_F_S/78_CM\2X]^_6(WQZRZIU^HON?>N_^&O[6GQI^&_B32M>\/>-?$&G
M7]OJEO+#>6FLZIY%GUS=&T^W8_E7S'3&C>17A2;R3)^Y^T<_N?3IQT_GS58_
M*LOKTL!2JX96Q>]HI.VSV7:Y?]HXN@\/5I8AM^K[]-=GL?Z07_!'C_@I'J7[
M:?PMM_"7Q'N+;5_BMX'EL(YK^VD\C_A)-!:[-J=?N[08&ZP-L2Q/+'D\YK]X
M:_@=_P"#:#5=1C_:UTW35N=D=Q\*O'^GW5O_ ,]K?1S9W=G=$#WNQ[]*_OB
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M?C_3\?K3]G+]A/\ 8P\4>"_^"<'A[6_V;]/O/$/[7_[+?QH\1>+?%'F^*/\
MB6^,/!^E7=[:71'V[@\]..W%?S>>!OVG/VA_A/\ #_6_@GX#^-OBSP9\-_'$
M6?%O@>WNK6?2KS_K[NOI]>_;BNUT3]NS]L/P_I?@:Y\*_M%?%S04^ ]A<:#X
M)DL[^V^P^#]/O/\ C[M?A[_S^V&HCVX(Z5EB<KQ]5_[+F'U1)MM7:NOJ=DNN
M\M]O*\@]O2H?Q</IWW]?PT/TM^"W[+'[*/Q@_89^-/B'2/ACX3\/?&S]C?XM
M6'_"\[B2_P!>@U7XJ? _1]=O+RTUZT_XGF?MVGWV/#_TLP#BNJ\'_LU_L?\
MA/\ 9(^!7[6WQ:\$ZQ?^#_VE/&_Q(-_XL\'Z-KWBK7/@_P#\(W:_8_AE_9&D
MV=]_H7_'V1JP]LU^&]K\4/B%9V?Q(O\ 0?'VIPP_%B7_ (NA9V>J7-C8^)-0
MO+K^V+NZ\1#_ )_M1^U_\3;'..E=_P""_P!K3]I/X9_#?7_@;\.?C?XP\*_"
MKQI%]OO_  ?X?E^W:'#I_P#R]W5I]NL/]"_I[<XC^Q\P5O99BW]_;7KWUN^C
MUZ"_M'"_]"^WG=H_7WQ1^QG^RIXF_8+UCXS? 'P[X3\<^.?A78>#K_X^^%_B
MY%KW@[XF>&[C6->L]8M/BAX3TG[=_IMCXAL1_P (_I.G]?[)O+^OO+QW^SE^
MSG\=/^"MGP-_9I^(7[.7@^?X,_\ #&]AXIB@T^+7;&>;4/\ A75GXD^T\7V,
M"^N\9QGCGG)/\OTG[1WQXUCP7K?@.]^)?BC_ (1CQ!I>G^'+JSU36;6"#4M.
MT>Z^V:3=7?\ V#KZT TGTZUZ+'^WQ^V>_C#P!X[C_:!^)<?CGX?^$C\*M!\:
M1WUK_P )5IWA<VOV3[+I/_/[8FQS8'^7-9O*,XNG_:,M+]7UM;1:/;K=KI:[
MN+'X;MU6EE]VQ^\/P'_9'_8O^)'P\_81^(,W[+'AVUU;X[_M8_$_]E?QQH\L
M_BC/B_X;>$+K6K*S\5,/MP^Q?$33OL5KM)P"5;GBO)U_87_8C_9]^%_QL^-/
MQ(\#:AXJ^'OAO]MS4/@/JFCZ?H/BGXCWWPW^%^CW7_(4\/>'M%O?[0T7XC?8
M?^8AJ/?O7X[:3^WA^U=X9M_!.E:5^T?\1-*\-^!_B#J&LZ/]GN;6"X\$_$#Q
M)G.O6G/34>?^)ATYZ8S3_#7[;G[9'@?4?BO-HO[0/Q,TW7OBS=7%K\4/[4O]
M+OM*\>'_ (\_[4^R7O\ R^ZC8_\ ,0/XU"R?/KOV>8M[VUD]+W2ULMM-%Y)V
M-L1F&5T+/ZNKV\M[=[?U<_:']DW]CO\ 9%\<?L]_!;XE^*_V>+?XF7GQ,_X*
M&^(/V??#EYXTU37M#OIOV?[RZ/\ 9/BCQ#X>^W?VA9^*].L;NTYU&DTGX3_"
M_P"!_P"QU_P7?MM'^"?A_P 3^(_@_P#M%^&/A5X$N-5T;5+[73\,/^$ILAI'
M]JW=[?$V5AIU]D\'K9XQSFOQ$\-_MJ?M/_#WPKX8\)>$OVA/'GAOP]X+\96_
MC+P;H=O+]H@_X61>77^B:I]K''_/W^M36_[9'[2'AMOC3>?\+O\ B@C_ !\N
MOM7Q^CM[^UO['Q5XQO.?M7V3_P#5]*'D>:5+>UQ334E+233=G>SUO9]=DUN3
MA\92KTG4I8=6_+4_0C_@@9:I'_P5)^&NI167]IZI<?#CXH2ZKJ&C_O['3?\
MBE_^/7/M_7BO@_XC?"OQ5XP_:,_:*U7_ (16\UO1/#?Q:N/B#\0;CQ!I]U!8
M6?A^S\>6=G_97VOU^PW?_P!;U\B^$/QP^*G[.^O_ /">? WXE^)/A7XJU6UN
M-!T?Q)X3U2T_X2JTU"\)^UB[M/3\.?:NM\7?M??M/^*O"?B3PCXG^-GQ(O\
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MZR7TSZ\_C]>]&+C_ )[VG_DI_P#%5[3_ ,,__$+_ * ]Q_X(M2_^0:/^&?\
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MR36>^//_ "U]_P#/\OK*//C:Y>#4K=[;4+K^U+^WN(K7^U9KB\M?L?\ 9?\
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M( RV./7J">_'/%?T)2(LMW(LB(RE[;J#G_CY!Y['^G->C7Q5=8;#VJ5/M_\
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MF0",L*/;8C_GY4_\&U/_ )(/98?^2G_X##_(V/\ A!? O_0E>$/_  1Z)_\
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MS;/7G)!ST-9JO37_ "Y;VZ>G8]!4_P#I_;UM]VQ_(9I?QI^,MW_P27_X(0^
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M8>([*[NAXK.HY_M4D =@9^L4O^@=_<P^KK_H)7H??/P>^)GA+XS?"SP!\6O
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MRW_AY1^Q)_T==\%?_!T/\_\ ZC[9_P L'_A:/Q#_ .@S>?\ ?E:/^%H_$/\
MZ#-Y_P!^5H_XA;A_^ABO_ 8_Y!_KOC_^?"/]4#_AY/\ L2?]'7?!?_P<#_'_
M #@^V6_\/*/V)/\ HZ[X*_\ @Z'^?_U'VS_E@_\ "T?B'_T&;S_ORM'_  M'
MXA_]!F\_[\K5_P#$+\+_ -#%_P#@$/\ (/\ 7?'_ //A'^I]_P /*/V)/^CK
MO@K_ .#H?Y__ %'VR[_AY/\ L2?]'7?!?_P<#_'_ #@^V?\ *_\ ^%H_$/\
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M?]^5KB_XA;A_^AE_Y+'_ "-WQQC_ /H'74_U/?\ AY3^Q+_T=;\&/_!U<_\
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ME<:]:Z/H]_:^'-*O-8L[7[9=Z#I.K:UD?;OL/_ZS7]+_ /P4!_9]\._M!_\
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MG\IWPH_9O^*_Q^\/_%KQ5\$_!EYXST'X,:#K'Q!^(VH1ZS:P0:#X/T?[8?\
M0^/]-_L[''?%>%+<Z5&TVI)<^=H^H:K<_P!EQBZ^W3V>G7EK9_9+6[M++I_I
MWVOT_"OZD_V-K;]GRX/_  4DU7]FOP-\3_!]M<?\$HO$-K\2_#_BCP'=>#K'
M0?BQHPO='\0VH\/7M]R=1-G=>(#[7A(]*/@O^R_^QOXP;_@ESX/F_9R\!W.E
M?M@?L>>*/$?Q>\87<.J?VKX5U?PUI5W9Z3XRM,G&C'3K_//']JYZ<9K:GQ]B
MOK;PV.PSLGNHO^6^NGW675;[EU,CG"G?3YVOO;??\=#^6F:W>U_<WMS]IO\
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M4?M@7$%]^U=^T)80_P#$DTW3/V@O'/@W2[?PWH-K!I6CZ/9^*+S1[2UM.?\
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M>:GK+_WZ_P#K5D!+147FIZR_]^O_ *U'FIZR_P#?K_ZU $M%1>:GK+_WZ_\
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M_2/ZIOVG/CY\'_'7[-'[9/AN']H?P'JOB?QC^W]X0^*OPODU#Q1Y^N6?P_\
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M -^O_K4>:GK+_P!^O_K4<]3L_N9'U>GY?C_D2T5%YJ>LO_?K_P"M1YJ>LO\
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M0 ?9X?\ GFOZ_P"-'V>'_GFOZ_XT44 'V>'_ )YK^O\ C1]GA_YYK^O^-%%
M!]GA_P">:_K_ (T?9X?^>:_K_C110 ?9X?\ GFOZ_P"-+Y$/_/-/^^1116^'
MU6NNGZ(TI]?E^H>1#_SS3_OD5!Y47]Q?RHHKMII:Z+I^IH'E1?W%_*CRHO[B
M_E116@7?=_>_\P\J+^XOY4>5%_<7\J** )OL\/\ SS7]?\:/L\/_ #S7]?\
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1[;MW;[G[WP5_R+UZ/_TH_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex23-2_01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-2_01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !) 2H# 2(  A$! Q$!_\0
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M*S]&VK];7ZA1116)J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MTK4-=US5[Z4,8[+2M'TJWN]2U&[=5=EMK.VGF*([A-B,1],?MW_\GR_MH_\
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MY;6/ OPU\.:C'9^*(K#Q/$L6F>)_%7B.RT-I= GU70])T6\75#K-E_)<  ,
M  <  8  Z  < #L!TK[CAK+\1@\/7J8F#I3Q,Z;A2EI.,*<9)2G'7E<Y3=HO
MWE&*<DFTE\?G^-H8NO1IT)JI&A":E4CK&4ZDHMQ@].914%>2]UR=DVDV?LI_
MP;^ZCXET_P#X*S?LQ+X:$[C4['XPZ5XECA1W1_"4OPB\8WNI&[5711:PZC8:
M-<B23>D5Y!9NL;2B+'^EY7\2/_!K+^QKKNL?$OXM?MT^+-$FM?!_A/PWJ/P1
M^#=_>VSQQ^(/%NOWUA>_$_Q%HLS,/.M?"FE:/IO@Z2[6-H)M1\1^(-/CE-SI
M%[''_;=7SO$]:G5S-Q@TW0H4Z-1K_GY>=246UU@JD8OLVUT:7N</4IT\O4IW
M2K5JE6"?\EH04EY3<)27=)/K=E<AK'Q!\!>'O$F@>#M?\;^$-#\7>*_-_P"$
M6\*ZQXET;3/$GB7R25F_L#0[V]@U/6?*8%9?[.M;GRR"&P0:Z34+Q=/L+Z_>
M-Y4L;.YO&BC_ -9(MM"\S1I_MN$*K_M$5_.7_P $^O\ @G_^R_\ \%$/^"=^
MD?M2_M<?"CP5\6?VG_V_M \7_&OX@?M"^(=&LM<^+_PPO_&WB/Q#+\+- ^!7
MQ!U-+OQ/\&]&_9_\)Q^$_#WPVT;X>ZKX=T_1+_PP=8>V?5=3U:>Z^=O)^T<8
MN4:-.%2HE)*<G5JSI4J=/FM#GJ2I5GS5&J4%"*FTZB</>LDJ=Y<KJU)4X-IN
M,?9TXU:E2?+>3A"-2DN6"=23FW'2#4OZ/Z*_GS_:%_X* ?%K]EGXG^ OV _
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M/N;0]I[1PIU$ESR2IM5(SG1A"<?AE[>EAJM*5W;EC/ZU",4_??Q^SY.:5/\
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M (*Q? ;2_&=_\$_B-^R[XG^+?[7'[+W[/?P?_:;^*_C?QW\4=)O?@?\ M(_
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?Z:^K=VXA"-.$*<;J,(QA%-W=HI)7;W=EJ]/1*R7_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
